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Vocabulary 
Engineered nanomaterials - any intentionally manufactured material containing particles in 
an unbound state, or as an aggregate or as an agglomerate and where; for 50% or more of the 
particles in the number size distribution, one or more external dimensions is in the size range 
1 nm to 100 nm. 
Protein corona – a dynamic layer of proteins and other biomolecules that spontaneously 
adsorb onto the surface of a nanoparticle, when the nanoparticle enters a biological fluid. The 
biological identity of the nanoparticle is then determined by this adsorption layer once the 
protein corona is formed. The biophysical properties of the nanoparticle-protein corona 
complex can very significantly compared to the nanoparticle alone, with consequent effects 
on the biological responses of cells or organisms. 
Adsorption – the process of biomolecule and/or solute accumulation at a cell membrane 
surface. Adsorption can be physical or chemical in origin. The biomolecular interactions of 
adsorption are governed by van der Waals forces, electrostatic attraction and/or hydrogen 
bonding depending on the substances and surfaces involved.    
Nanoparticle dissolution - the dynamic process by which atoms or molecules from the 
surface of a nanoparticle goes into the solution phase; such that the dispersion contains a 
homogeneous mixture of particles and dissolved solutes derived from the surface of the 
particle. The degree of dissolution is dictated by the solubility of the material and the 
available surface area for dissolution, in addition to traditional factors in solution chemistry 
such as temperature, pH, and ionic strength. As for any material, it is a prerequisite that the 
constituent molecules must be soluble to some degree in the local environment in order for a 
nanoparticle to dissolve. 
Enamel – the superficial layer that covers the crown of the tooth and is the hardest and most 
highly mineralised tissue in the body (96% w/w). The high mineral content renders enamel 
very strong, but also accounts for its brittleness. Enamel apatite consists of calcium 
hydroxyapatite and is highly crystalline with most crystals to be hexagonal.  
Dentine – a hydrated composite mineralised tissue that underlies enamel and forms the bulk 
of the tooth. Dentine is 70% inorganic, 20% organic and 10% water by weight. The mineral 
phase is hydroxyapatite, similar to enamel, but dentine crystals have lower calcium content 
and are much smaller. The organic component of dentine is mainly collagen and is a 
permeable tissue due to the presence of the dentinal tubules.      
Dental material - a substance or combination of substances specially prepared and/or 
presented for use by authorised persons in the practice of dentistry and/or its associated 
procedures.  
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The medical applications of engineered nanomaterials (ENMs) are relatively well-known. 
These include antibacterial coatings for medical instruments and wound dressings (e.g., self-
sterilising TiO2 catheters;1 nano-ZnO composite bandage2), the use of nanoencapsulation 
technology for improved drug delivery,3,4 as well as exploiting the optical properties of 
nanomaterials  for enhanced medical imaging.5 Some of the clinical aspects above (e.g., 
antibacterial ENMs) are particularly relevant to the oral cavity, and the role of ENMs in the 
control of the oral biofilm has been recognised.6 Although the use of ENMs in dental 
applications has received some commentary,7,8 a detailed evidence-based review has not been 
conducted, even though the use of nanotechnology in dentistry and dental materials has been 
the epicentre of extensive research in recent years. 
In the oral cavity, non-clinical or occupational exposures are dependent on the use of  
nanoparticles (NPs) in food9,10 and personal care products, such as  dentifrices.11 TiO2 NPs 
are the most commonly used in food and personal care products (also known as E171 in food 
products, with 36% of the particles < 100 nm12). The ingestion of TiO2 via food is estimated 
to be relatively high (5 mg TiO2/person/d);13 half of which is in nano-particulate form.14 
Numerous studies have investigated the potential toxicity of ENMs,15,16 but the data is sparse 
on cells relevant to the oral cavity; although there is interest in using engineered and 
naturally-occurring NMs to manipulate the cells/tissues associated with dentition (e.g., 
controlling differentiation of pulp stem cells17). Some oral exposures have been done with 
rodents in vivo,18,19 but none of these have collected samples to investigate potential 
pathologies in the oral cavity. Such data will be important in quantifying the risks of ENMs 
in the oral cavity, and be important in supporting the notion of responsible and safe 
innovation of nanotechnology in dentistry.  
As with any new medicine or medical device, the potential benefits must be weighed 
against the risks.20,21 In terms of adverse health effects, there is an historic literature on the 
occupational exposure to dusts containing ultrafine particles22 and the concern of respiratory 
toxicity from inhaling ENMs has also been reviewed for different ENMs (CNTs;23,24 metal 
particles and silica25), with a particular focus on high aspect ratio ENMs that may cause acute 
inflammation in the lungs.26 However, most of this literature has been concerned with events 
in the lung, not the oral cavity, and traditionally these experiments have used free forms of 
ENMs in aerosols or instillations, not ENMs that are trapped in the matrix of a commercial 
product, in semi-solid materials like food, or in a dental material. 
This review illustrates the evidence base for the applications of ENMs in dentistry. 
The electronic search was conducted applying a combination of subject terms and keywords 
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on PubMed, Medline, Scopus and Web of Knowledge databases. The electronic search terms 
focused on the four main application fields in dentistry (as antimicrobial agents, fillers in 
dental composites, dental implants and in personal care products for the oral cavity) as well 
as the potential toxicity caused by ENMs in vivo following oral exposure. The keywords 
applied to the search databases were: (nanomaterials OR nanoparticles OR nanocoating OR 
nanotechnology) AND (antimicrobial OR antibacterial OR infection OR biofilm OR filler 
OR composite OR implant OR dentine OR enamel OR demineralisation OR remineralisation 
OR dentifrice OR toothpaste OR mouthwash OR oral product OR in vivo oral exposure 
toxicity) AND (dentistry OR dental OR oral). Quality criteria included considerations of 
experimental design in the published literature such as the use of appropriate bulk material or 
metal salt controls, and inclusion of information on at least the characterisation of the starting 
material such as chemical composition, primary particle size as well as size distribution 
where relevant. Papers with inadequate material characterisation, or poor descriptions of 
methodology or replication were excluded. The examples were also chosen to show a 
representative selection of materials, applications, and the historical chronology of the 
development of ENMs in this field. Selected examples from the published literature are 
presented in Tables 1-5. 
The aims of this review were to: (i) reflect on the ultrafine structure, chemical 
composition and reactivity of teeth in the context of interactions with ENMs, and to set the 
scene on the nanoscale biology and surface film events in the oral cavity, (ii) describe the 
main actual and proposed applications of ENMs in dentistry, and (iii) put the dental 
applications in context of clinical outcomes versus potential hazards as well as risks. Finally, 
(iv) key knowledge gaps are identified with some recommendations for future research. 
 
The properties of saliva and the behaviour of ENMs 
Saliva is a complex mucous secretion that functions to maintain the pH in the oral cavity, 
mostly via bicarbonate and some calcium phosphate buffering.27 Acids derived from the 
consumption of food and drink, and/or bacterial metabolism are neutralised by bicarbonate 
(Figure 1B) in order to prevent acid erosion of the teeth.28,29 Additionally, saliva has a rinsing 
effect on teeth and contributes to bacteria clearance, but it also contains antibacterial proteins 
(e.g., lysozyme, iron chelators such as lactoferrin) as well as components of the immune 
system (e.g., immunoglobulins). Clearly, the antimicrobial properties of ENMs are of interest 
in relation to the latter functions (see below), but the behaviour of ENMs in saliva will also 
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be influenced by the pH, electrolyte composition, and viscous properties of the mucus 
components.  
It is not our intention here to detail the complex physico-chemistry of ENMs in 
biological media, but to appreciate the importance of the colloidal properties of ENMs that 
might be important for saliva. Firstly with respect to colloid chemistry, most ENMs are not in 
true aqueous solution but are dispersed in the liquid phase; with the aggregation of the 
materials being particularly influenced by the ionic strength of the medium, the presence of 
divalent ions like calcium, pH, and the presence of organic matter.30-33 Saliva is 99 % water 
and is a high ionic strength medium containing numerous electrolytes. The exact electrolyte 
concentrations in saliva can vary, but it normally contains (in mmol l-1); sodium (2-26), 
potassium (13-40), phosphate (2-22), calcium (0.5-2.8), chloride (8-40), iodide (2-22), 
bicarbonate (0.1-8), magnesium (0.15-0.6), and a trace amount of fluoride (usually at µmol l-
1). These concentrations may be higher in freshly stimulated saliva.34 The millimolar 
concentrations of NaCl and the divalent ions such as Ca2+ and Mg2+ will tend to promote 
particle aggregation.31 Consequently, similar to physiological salines,35 saliva may promote 
the settling of aggregates of the ENM onto the surfaces of the oral cavity.  
The resulting effects of ENMs in a dental material on the bulk electrolyte functions of 
saliva are likely to be modest, since the millimolar concentrations of NaCl and Ca2+ in the 
saliva would (theoretically) be in excess of any labile ENM derived from the tooth surface. 
For example, Besinis et al. found only negligible low micromolar release of silver from 
dentine slices coated with Ag NPs.36 The rheology and viscous properties of mucous 
solutions are mainly derived from the effects of charge screening by electrolytes on the 
protein folding of mucins.37 Provided the ion concentrations remain at millimolar levels, the 
effects of ENMs on the rheology of saliva are expected to be small. For similar reasons, the 
general pH buffering in saliva from millimolar concentrations of phosphate and bicarbonate 
might also be unaffected. However, ENMs often have a high surface area to volume ratio and 
it is possible that solutes such as fluoride, that are only present at micromolar concentrations, 
could be adsorbed by some ENMs.  The F- ions in saliva can react strongly with the free Ca2+ 
and HPO42- ions available in the hydroxyapatite (HA) of enamel to form fluorapatite crystals 
that are less soluble and more resistant to acids compared to pure HA (Figure 1B). This is one 
of the benefits of fluoride in preventing dental caries, and theoretically this function may be 
lost, especially with ENMs with a net cationic charge in the saliva. Unfortunately, the effects 
of ENMs on the bioavailability of important trace anions have not been investigated.  
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The salivary flow rate also controls the solute concentrations in the oral cavity. 
Factors such as age, diseases and medication can impair the quantity (and quality) of saliva. 
The reduction or absence of the salivary flow usually results in increased food retention, and 
when the salivary buffering capacity has been lost, an acid environment is encouraged 
causing enamel demineralisation. In a healthy person, the unstimulated (resting) salivary flow 
rate is 0.3-0.4 ml min-1 and may increase to 1.5-2.0 ml min-1.34 When saliva is initially 
secreted, it is sterile, but subsequently the bacterial concentration can reach 109 ml-1. Salivary 
flow rate is normally too high to allow bacterial growth and proliferation in the fluid.38 
Instead, bacteria need to adhere on an oral surface (teeth, mucosal tissue) to survive in the 
long term. The secretion of saliva is mainly controlled by cholinergic parasympathetic 
innervation to the salivary glands which promotes the release of saliva from the acinar cells, 
whilst in contrast; stimulation of sympathetic nerves tends to increase the protein content, 
resulting in a more viscous saliva.39 Evidence suggests that direct application of high 
milligram concentrations of ENMs to isolated nerve preparations do not alter the ability of 
peripheral nerves to generate an action potential,40 but the effects of ENMs on the secretory 
activity of salivary glands have not been investigated.  
Saliva also contains immunological components (e.g., IgA, IgG and IgM) and 
antibacterial proteins (e.g., lysozyme, lactoferrin, and peroxidases). The effects of ENMs on 
the bioavailability and function of these immune-related components of saliva have not been 
specifically investigated. However, immunoglobulins and complement factors involved in 
immunity from serum do adsorb to ENMs, depending especially on the surface charge and 
hydrophobicity of the material.41 Lysozyme is also adsorbed onto the surface of some ENMs 
resulting in an alteration of the spatial arrangements of the β-sheets in the enzymes tertiary 
structure with a likely loss of its antibacterial properties (e.g., TiO242). In contrast, some 
ENMs have peroxidase-like chemical reactivity,43 and such materials could be exploited for 
their antimicrobial properties. There are numerous other organic components in saliva 
including the mucin glycoproteins, agglutinins, histatins, proline-rich proteins, statherins, and 
cystatins.44 The effects of ENMs on many of these proteins/peptides are unknown.  
 
The tooth surface microenvironment and interactions with ENMs 
Substances in saliva do not interact directly with the tooth enamel, but do so via a thin layer 
known as the pellicle, which usually covers the dentition (Figures 1A and B). The pellicle is 
an acellular proteinaceous film of salivary origin that is usually formed within minutes, and it 
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is so strongly adhered to the enamel that even tooth brushing does not remove it. The 
thickness of the pellicle is 10-20 nm with a few minutes, increases to 20-500 nm at 2 h and 
reaches 100-1300 nm at 24 h.45 The main constituents of pellicle are salivary glycoproteins, 
phosphoproteins, lipids, and to a lesser extent, components from the gingival crevicular 
fluid.46,47 The pellicle plays an important role in the tooth demineralisation and 
remineralisation processes because it passively controls the diffusion of ions in and out of the 
dental tissues. It is therefore a selective semi-permeable structure that is regarded as a 
chemical buffering barrier, protecting the mineral content of the enamel from bacterial48 and 
dietary acid demineralisation.49,50 However, the structure of newly formed pellicle may not 
prevent the penetration of ENMs. The enamel-pellicle interface is not homogenous, but has a 
multi-layered globular structure.51 The size of these spherical structures ranges between 25 
and 125 nm in diameter, and quite often voids are also observed, as the distance between 
adjacent globules is from 8 to 85 nm (sizes and distances measured from electron microscopy 
images of a 2 h pellicle52). It is therefore theoretically possible that ENMs smaller in size than 
these voids could penetrate the pellicle as it forms. However, once the proteinaceous biofilm 
is present over the globular structure of the pellicle, it seems likely that steric hindrance and 
protein-ENM interactions would slow or prevent further diffusion of the ENMs into the 
pellicle layer. 
 The process that forms the proteinaceous layer of the pellicle is not fully understood, 
but is presumably governed by the colloidal and physico-chemical properties of the 
macromolecules in saliva, such as the charge density, hydrophobicity, and relative 
concentration of each component to compete for binding on the tooth surface. Much the same 
ideas apply to the formation of the “protein corona” on ENMs in complex body fluids such as 
serum.53-55 It is therefore logical that any ENMs present in the saliva will compete with the 
pellicle surface for proteins and other macromolecules in the saliva. The newly formed 
protein corona of ENMs (Figures 1A and B) will inevitably alter their physico-chemical 
properties. For example, adsorbed proteins may alter the net surface charge on the ENMs 
(changes in zeta potential and isoelectric points of NPs56); and consequently the charge 
screening with electrolytes and the agglomeration behaviour of the ENMs in the saliva itself. 
In theory, the interactions of the coated ENMs with the pellicle will also be influenced. It also 
follows that a tooth coated with an ENM of defined surface chemistry could be used to 
manipulate the formation of the pellicle. The latter may be of interest for preventing 
microbial colonisation of the teeth, for example, by providing a surface that does not favour 
microbial adherence. Bacteria are probably non-specifically associated with the tooth surface 
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(Figure 1B) under the effect of van der Waal’s attractive forces as well as repulsive 
electrostatic forces.29 Surface hydrophobicity generally enhances the attachment of microbes, 
and consequently a hydrophilic ENM coating might reduce the attachment of microbes.  
Numerous studies have examined the antibacterial effect of NPs incorporated in the 
matrix of dental materials against mostly individual oral pathogens (see Table 1), while other 
research groups have investigated the antibacterial activity of NPs suspended in biological 
media containing microbes.57,58 However, the antimicrobial effects of ENMs in complex 
clinically-relevant biofilms such as that on the pellicle is far from clear. In general, the 
microbial communities in natural biofilms tend to be more resilient than the artificial cultures 
of individual species of microbes in the laboratory. For example, while Ag NPs are known 
for their antimicrobial properties on S. mutans,36,58 the same material has no effect on the 
natural microbial diversity in marine biofilms that also include Streptococcus species.59 The 
biodiversity of gut microflora is also influenced by metallic ENMs in some animals (e.g., fish 
gut60), but a similar understanding for the oral cavity biofilm of humans is lacking. 
Although, some ENMs may be small enough to theoretically permeate into the porous 
mineral structure of the enamel-pellicle interface (above), it is likely that the biofilm formed 
on the pellicle will be a significant barrier to ENM diffusion; either through steric hindrance 
(e.g., ENMs becoming trapped or entangled with the biofilm protein matrix), or by adsorption 
of the ENM onto the glycoprotein coat of the S-layer of microbes.61 Permeation into biofilms 
is partly controlled by biofilm thickness. Diffusion works most efficiently over small 
distances of a few microns and is exponentially slower for small increases in particle 
diameter.62 The diffusion path through the biofilm will also be determined by the micro-
architecture of the biofilm; which is defined by the participating species and the conditions 
under which the biofilm is developed (potentially, every biofilm is unique in this respect). 
Channels and voids are known to be present in the oral biofilm. Plaque models have shown 
that the open channels can be 300 nm in diameter,63 which theoretically would be large 
enough to allow ENMs to permeate. However, diffusion theory based on the original Fick 
equations is idealised and does not take into account solvent drag or steric hindrance from 
proteins in the biofilm. Consequently, even small NPs (< 20 nm) may find it difficult to 
penetrate the biofilm. For example, Thurnheer et al. found that 240 kDa molecules had 
difficulty in infiltrating the oral biofilm.64 The volume occupied by a molecule of this size is 
approximately 290 nm3 and thus it would be equivalent to a spherical NP of just 4 nm in 
diameter. 
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Furthermore, it is also likely that the ENMs diffusing into the biofilm will not be 
pristine, but coated in macromolecules and electrolytes from the saliva. Although the protein 
corona formation on ENMs in saliva has not been specifically studied, chemistry would 
suggest (for example) that the polyanionic mucins in saliva would bind electrostatically to 
cationic ENMs, and/or that the bulk electrolytes in saliva will form an electric double layer 
on the surface of the particles.31 The process is also likely to be dynamic with microbes 
secreting proteinaceous material as the biofilm develops and the bulk fluid movements into 
the pellicle enabling some adsorption of ENMs into the biofilm (the latter adsorption partly 
being governed by unstirred layer formation in the case of solutes65). 
Nonetheless, understanding of how EMNs coated in a salivary corona will interact 
with the biofilm, and the microbes within it, is a significant data gap in quantifying the 
bioavailability of oral ENMs. Experiments are needed to determine the details of how the 
adhesion of ENMs on the dental surfaces is regulated, as well as the likely complex 
interactions of the ENMs with the bacteria, their secretory products, and the proteins forming 
the underlying pellicle layer. Currently there are no computational models for ENM binding 
to biological surfaces, but ENM adhesion or adsorption is likely to be governed by the 
chemistry of the pellicle and overlying biofilm (plaque), since the ENMs would not be in 
direct contact with the chemistry of the enamel surface. Any such biotic ligand type-model 
would need to consider the effects of the ionic strength and its likely ability to erode the 
electric double layer on the particle surface;31,66,67 the role of protein corona formation to 
sometimes encourage colloidal stability68-70 or alternatively promote agglomeration71-73  
depending on the precise mixture of ions and macromolecules present in the media. ENMs 
can also impose structural and functional changes to the adsorbed proteins,74 although the 
functional consequences for the saliva, pellicle, and biofilm remain to be investigated.      
 
The interaction of ENMs with the fine structure and chemistry of the tooth 
 
The gross anatomy and fine structure of human teeth are well known,75 but here the 
anatomical and chemical characteristics of the tooth are considered in the context of potential 
interactions with ENMs (Figure 1). Teeth consist of four different tissues, of which three are 
mineralised (enamel, dentine, cementum), and surround an inner core of loose connective 
tissue; the dental pulp (Figure 2). The chemical composition of each tissue is outlined below. 
Enamel 
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Enamel covers the crown of the tooth and is the hardest and most densely calcified tissue in 
the body. Its thickness varies as a function of location and age in the tooth76 and can be 
between 2.6 mm over the cusps of sound mature teeth, and as low as 1.2 mm on the lateral 
surfaces.77 Ninety six percent of the enamel by weight consists of mineral, with water and 
organic material composing the rest.78 Calcium hydroxyapatite (Ca10(PO4)6(OH)2) is  the 
most dominant constituent of enamel, although minor (< 2 %) non-apatitic mineral phases, 
such as octacalcium phosphate, can be detected. Calcium hydroxyapatite (HA) does not 
always exist in its pure form, but commonly other variations are also present. Calcium ions 
(Ca2+) and hydroxyl groups are frequently missing and thus replaced by other ions present in 
the enamel such as fluoride (F-), carbonate (CO32-), chlorine (Cl-), silicon  (usually as SiO44-), 
sodium (Na+), magnesium (Mg2+) and  zinc (Zn2+). The distribution of these ions is not even 
across the enamel layer (Figure 1B). Some of them (F-, Cl-, Si, Zn2+) appear at higher 
concentrations near the external surface of enamel, while others (Na+, Mg2+, CO32-) are more 
abundant near the dentino-enamel junction (DEJ).79,80 Enamel apatite is highly crystalline, 
with the crystals being at least 100 µm long, 30 nm wide and 90 nm thick.81 Most crystals are 
hexagonal (Figures 1A and B) but some can be distorted due to crowding. Dental enamel has 
558 crystallites/mm2 near the tooth surface82 and the distance between adjacent crystallites is 
20 nm.83 HA crystals are surrounded by a thin film of firmly bound water (2 wt. %). The 
presence of water is associated with the porosity of the tissue.  The remaining 2 wt. % in 
mature enamel is the organic matrix. Enamel does not contain collagen, but it has two unique 
classes of proteins called amelogenins and enamelins.  
The ability of ENMs to permeate or adhere to the tooth enamel is poorly understood. 
Enamel is permeable to electrolytes, although in this dense and highly mineralised tissue this 
is most likely via inter-crystalline spaces, rod sheaths, and other defects in the surface.84-86 
Nguyen et al. confirmed some innate permeability of human enamel using the Brunauer-
Emmett-Teller (BET) gas adsorption method giving a BET surface area, pore volume and 
pore size of 0.22 m2 g-1, 2.8 mm3 g-1 and 22 nm respectively.87 There appears to be no data 
showing whether or not ENMs are capable of permeating enamel. However, Li et al. report 
the use of 20 nm HA particles to repair dentinal enamel.88 Cai et al. also suggested that HA 
NPs with sizes < 20 nm could integrate with the surface of enamel matrix; but highlighted the 
importance of particle size with the use of 20 nm particles being more advantageous than 40 
or 80 nm HA particles.89 The exact type of bonds developed between ENMs and the enamel 
remains unclear, although it seems probable that electrostatic and van der Waals forces will 
be involved.90,91 
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Dentine 
Dentine is about 70% inorganic, 20% organic and 10% water by weight.92 The mineral phase 
is HA, similar to enamel, but dentine crystals have a lower calcium content and are more 
carbonate-rich compared to stoichiometric HA. The crystallites are much smaller than those 
found in enamel, having a hexagonal or plate-like morphology, and with dimensions of 3-30 
nm in cross-section and about 50 nm in length.93,94 The HA crystals are therefore naturally 
occurring nanostructures, and with high concentration of carbonate (4.6 wt. %) renders the 
dentine a large and chemically reactive surface area.95 Fluoride, sodium and magnesium have 
also been detected in dentine in small amounts (Figure 1B). The inorganic part of dentine is 
mainly type I collagen that provides the structural backbone which holds together the apatite 
crystallites. The fibril diameter in dentine collagen varies from 60 to 200 nm.96  
Dentine is permeated by characteristic microscopic channels called dentinal tubules 
(Figs. 1B and 2). Their diameter ranges from 2.5 µm near the pulp, to 1.2 µm in the middle of 
dentine, and 900 nm near the DEJ.97 The tubule density also varies depending on location. 
The number of tubules near the pulp is 45,000 mm-2 covering 22% of the total surface area of 
dentine, in the mid portion there are 29,500 mm-2 tubules, and the corresponding value near 
the DEJ is 20,000 mm-2 where the percentage tubule area is just 1%.95,97  
The application of ENMs to dentine has received more attention (see dentifrices and 
personal care products section) compared to enamel (Table 4); mainly because dentine 
remineralisation is not so predictably achieved. Dentine is more porous than enamel due to its 
organic components, higher water concentration, and the presence of dentinal tubules. 
Consequently, ENMs of larger diameters may infiltrate dentine than enamel. Earl et al. 
managed to infiltrate dentine tubules with 100 nm HA particles finding that the shape of the 
ENMs was also important.98 In the same study, larger needle-like HA particles up to 600 nm 
in length and 30-60 nm in width showed very limited infiltration. When demineralised 
dentine was treated with HA nano-rods having an average size less than 100 nm (variation in 
particle length was between 30 and 145 nm), 50% of the tubules at the dentine surface were 
fully occluded and an additional 40% were partially occluded.99  
Most studies investigating the infiltration of dentine with ENMs use a partially 
demineralised dentine model. Consequently, interfibrillar and intrafibrillar infiltration is also 
possible as removal of the inorganic components during demineralisation results in larger 
voids between the collagen fibres.100 Using a fully demineralised model instead, Besinis et al. 
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achieved an extensive infiltration of the collagen network with spherical HA and silica NPs 
when the particle size was less than 15 nm in diameter;101 in agreement with measurements of 
the inter-fibrillar spaces after demineralisation of between 20–25 nm.102,103 In a follow-up 
study, Besinis et al. confirmed the remineralisation potential of fully demineralised dentine 
following infiltration with HA and silica NPs.104  
 
Cementum 
Cementum is a thin specialised calcified, fibrillated bone substance that covers the dentine of 
the root (Figure 2). By weight, the cementum is approximately 65% inorganic material 
(mainly HA), 23% organic (collagen type I, proteins and polysaccharides) and 12% water. 
The HA crystals in cementum are thin and plate-like with an average size of 55 x 8 nm. The 
thickness of cementum is considerably higher at the root apex (50-200 µm) compared to the 
cervical part of the tooth (10-15 µm).105 There appears to be limited studies of ENMs in the 
cementum layer of the tooth, or on the cementocytes (e.g., effect of bioactive glass NPs on 
cementoblasts106). 
 
Pulp 
Pulp is located in the pulp chamber, which occupies the central portion of the tooth (Figure 2). 
The nerves present in the pulp allow detection of external stimuli and account for the 
sensation of teeth. The main function of the pulp is the formation of dentine.107 The 
odontoblasts that are responsible for the formation of dentine lie along the periphery of the 
pulp tissue. Other cells present in the pulp include fibroblasts, pre-odontoblasts, macrophages 
and T lymphocytes.  
 One prospective area of research for the dental pulp is the use of ENMs in 
regenerative medicine. Pulp stem cells can be used as a restorative clinical treatment to 
regenerate both the pulp and vasculature in the tooth.108 Dysfunction of stem cell 
differentiation is also generally implicated in DNA damage and tumorgenesis in the head and 
neck.109,110 ENMs have been proposed for medical imaging of stem cells (iron NPs, quantum 
dots) in order to track the migration and differentiation of the cells, as well as the use of 
nanofibre scaffolds to aid the regeneration of pulp tissue.17 Naturally occurring 
nanostructures such as nanotoliths with bacterial cellulose have also been proposed as 
scaffolds for pulp regeneration.111 
 
Page 13 of 61
ACS Paragon Plus Environment
ACS Nano
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
13 
 
Current Strategies for Clinical Dentistry - A role for ENMs? 
The aetiology of pathogenesis in the oral cavity is complex, and a primary strategy for 
dentistry is the prevention of disease. Oral hygiene instruction for the patient is the first 
attempt in preventing both carious lesions and periodontal disease.112,113 Clearly, the use of 
antibacterial and/or abrasive ENMs in toothpaste may aid teeth cleaning. However, ultimately, 
the dental pellicle is the natural barrier that protects the hard tooth structures and the 
supporting tissues from the adverse effects of microorganisms and their corrosive 
metabolites.114 The antibacterial properties of some ENMs could be used to supplement the 
natural immune defences (e.g., immunoglobulins, lysozyme) already present in the pellicle. 
The dental pellicle, however, is also the structure in which bacterial colonisation begins. 
Perhaps ENMs can be designed to act as receptors for species-specific bacterial adhesion to 
the tooth surface; in essence, using ENMs as a “probiotic” surface to promote healthy 
microbes in the pellicle, or to aid in the restoration of a normal biofilm following dental 
treatment. The demineralisation of the tooth structure caused by acidic bacterial metabolites 
might be ameliorated by the use of alkali ENMs, which for example, might slowly release 
phosphate or bicarbonate buffering by dissolution (pH control at the tooth surface). The 
inflammation of the soft tissue by factors such as lipopolysaccharides (LPS) released by 
bacterial infection of the biofilm115 may be hard to prevent with specific chemical buffering 
because of the diversity of bacterial exudates. Nonetheless, metallic ENMs do absorb LPS 
very well116 and might reduce the bioavailability of this inflammatory agent.  
Furthermore, dietary abrasion of enamel during mastication has been hypothesised to 
release naturally occurring nanoscaled HA particles, which are known to reduce oral biofilm 
formation and produce a remineralisation effect to prevent carious lesion progression.117 With 
soft diets of today consisting of less protein and increased carbohydrates, the release of 
protective nanoscale HA is likely to be in decline; contributing to growing incidence of caries 
in the human population.117-120 Potentially, toothpastes and other oral hygiene products could 
be supplemented with engineered HA to combat this problem, but the underlying cause of 
poor diet also needs to be addressed.  
The dental materials of today are greatly challenged by secondary disease (e.g., recurrent 
caries) after initial treatment is one of the main reasons for failures in dental materials.121-124 
For this reason, an interest in the bioactivity of dental materials is increasing, as materials 
need to go beyond the physical and mechanical aspects of tissue repair. In direct tooth 
restoration with new composite materials, such things as wear resistance, surface hardness, 
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fracture toughness and compression, tensile and flexural strengths are needed to meet 
demands of mastication in the oral environment.125-127 While improvements in these areas are 
being accomplished for direct restorative materials, several limitations are still found for 
modern materials.127 The difficulties include; adapting the material to the internal surfaces of 
a prepared cavity, creating an effective marginal seal at the cavity tooth interface, marginal 
deterioration over the life of the restoration, material discolouration over time, secondary 
decay caused by material microleakage, and post-operative sensitivity.128,129 Nanotechnology 
has the potential to bring improvements in the physical properties of dental materials, but the 
bioactivity aspect should not be overlooked. This might include biocidal properties of ENMs, 
as well as ENMs coated in factors to promote a beneficial immune response in the diseased 
tissue (e.g., cytokines, compliment activation), and subsequently growth factors to promote 
angiogenesis and wound repair.  
Restorative dentistry has traditionally focused on the use of dental materials to replace 
tissue in the oral environment in order to restore physical function following tissue loss from 
disease processes.130 Although success with respect to mechanical function is often achieved, 
the broader biological function of the tissue is not. The mechanical and biological properties 
of living teeth are intimately related. Odontoblasts are key cells in tissue regeneration, and 
function in tertiary dentine development to protect the vital pulp from any continuation of 
disease processes or trauma.131,132 New ENMs that promote pulpal cell repair and cell 
differentiation may increase dental pulp vitality during or after restorative processes, and 
ultimately improve oral health. 
 In the periodontium, regeneration of bone which has been lost due to periodontal 
disease could be a vital step in the cessation of disease itself; where periodontal pocketing 
creates disease-promoting architecture in the oral environment.133 For example, engineered 
nanostructures could be used as a bone replacement,134 or ENMs that promote 
osseointegration (e.g., coated with HA) and/or bone regeneration could be used. It the 1990s 
it became apparent that enamel matrix proteins (EMPs) could promote fibroblast proliferation 
and growth, and commercially products, such as the enamel matrix derivative Emdogain®, 
and similar products that contain factors such as amelogenin are used in new regeneration 
therapies for tissue loss caused by periodontal disease. The use of such derivatives highlights 
the importance of bioactive materials in modern therapeutic strategies against periodontitis.135 
The use of ENMs to provide a more targeted drug delivery of such therapeutics in dentistry 
has yet to be explored. 
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Engineered nanomaterials and their use in dentistry 
Antibacterial - Infection control 
Silver, zinc and copper have been traditionally used as antimicrobial agents for many 
centuries. Metals and their oxides have been incorporated in a wide range of dental 
applications, either alone, or in combination with other components;136 and there is interest in 
replacing the traditional micron-sized antimicrobial metal powders with their nanoscale 
counterparts (Table 1). The superior bactericidal activity of ENMs is attributed to their 
increased surface area, as well as the possibility to interact directly with the bacterial cell wall 
because of their small size. Nano-particulate silver is the most favourable antimicrobial agent 
among the metals;137-140 followed by TiO2.124,141 Zn and ZnO NPs have also been suggested 
for use in dental applications due to their antibacterial properties.142,143 However, the number 
of the applications of nanometals in dentistry is limited, and for example, Zn does not have 
the acceptance it has in other fields such as the food industry.144 CuO is cheaper than Ag, 
with the advantage of being a stable chemical, and with physical properties that allow it to be 
easily mixed with polymers.145 However, Cu NPs have not been fully investigated as 
potential antibacterial agents in dental materials. Similar arguments apply to Au NPs.  
Ag NPs may be favoured over other nano-particulate metals because silver is more 
bactericidal, while equally hard. In a comparative study, Besinis et al. showed that Ag NPs 
are more antibacterial against cariogenic bacterial species when compared to other metal 
NPs.58 Ren et al. found the minimum bactericidal concentration (MBC) of Ag, ZnO and CuO 
against Pseudomonas aeruginosa to be 100, > 5000 and 5000 µg ml-1 respectively.145 The 
corresponding MBC values against Staphylococcus aureus were 100, 2500 and 2500 µg ml-1; 
confirming the supremacy of Ag NPs. At the same time, silver, copper and zinc all score 2.5-
3.9 on the Moh’s scale of hardness (titanium scores 6.0).  
The size and shape of metal ENMs may also affect their bactericidal activity. 
Materials with a particle size of less than 10 nm have been shown to be the most effective 
against bacteria,146,147 while triangular NPs may be more bactericidal compared to spherical 
or needle-like morphology.148 Conversely, Suwanboon et al. found the antibacterial activity 
of ZnO NPs of different shapes (nano-rods, platelet-like, nano-flowers) to be similar.149 
Metal-containing NPs are not the only type of ENMs known to provide antimicrobial 
properties to dental materials. Quaternary ammonium polyethylenimine, chitosan, silica and 
bioactive glass NPs have also been suggested.150-152  
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The choice of antibacterial ENMs mainly depends on the type of dental application. 
For example, Ag, Zn and TiO2 NPs are commonly incorporated in resin-based composites, or 
used as antimicrobial coatings for dental material and implants; while others such as 
bioactive glass nano-powders are mostly used as root canal disinfectants (Table 1). Silica NPs 
have been reported to inhibit bacterial adherence and control the growth of the oral 
biofilm.153,154 Although silica NPs have no inherent bacterial toxicity, it is likely that it is the 
unfavourable substrate (surface morphology and chemistry of silica NPs) which prevents or 
delays bacterial adherence and biofilm proliferation. The antimicrobial activity of some 
ENMs can be enhanced with UV light (e.g., crystalline TiO2 NPs124). Certain metallic NPs 
(e.g., Ag and Cu NPs) have been proved effective against a wide range of bacterial strains 
including S. mutans. S.aureus, P.aeruginosa, E. coli, E.faecalis, S. sobrinus and 
S.epidermidis,155,156 while others  are more bacteria-specific depending on their mechanism of 
action (e.g., ZnMgO NPs show highly specific antibacterial activity to Gram-positive 
bacteria157).  
In order for ENMs to be generally accepted as replacements for the traditional 
antibacterial agents, they must first satisfy the regulatory requirements of any potentially new 
therapeutic of being safe, or safer than the existing product, and more effective.158 
Additionally, any therapeutic agent should not compromise the integrity of the dental 
materials. Confidence in new nanotechnology may come from using ENMs as carriers for 
traditional antibacterial agents. For example, composites based on the release of 
chlorhexidine, the active ingredient in mouthwashes.159 However, such an approach may 
suffer from the short-lived effectiveness of chlorhexidine.160 In contrast, impregnation of 
bactericidal NPs into resin-based composites has demonstrated a long-lasting effect against 
cariogenic bacteria without affecting the physical and mechanical properties of the dental 
material.137 
 
Nano-fillers 
Some selected examples of the use of ENMs as fillers in dental composites are shown in 
Table 2. Dental composites generally consist of three main components which are chemically 
different from each other: the organic matrix (usually a synthetic monomer or resin), the 
inorganic matrix (the filler) and a coupling agent (usually silane) to bond the filler to the 
organic matrix. Each of these phases can be modified and the resultant combination of the 
three components determines the physical, chemical, mechanical and optical properties of 
Page 17 of 61
ACS Paragon Plus Environment
ACS Nano
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
17 
 
composites; as well as their clinical behaviour. The introduction of new materials in the last 
few years, such as phosphine oxide initiators and monomethacrylate diluents,161 has led to 
dental composites with improved properties. However, it was not until the introduction of 
nano-fillers where significant new advances in the composites were developed (Table 2).  
The chemistry, the morphology and the size of filler particles used in dental 
composites vary significantly, even within the nanoscale (Table 2). However, the aim of 
incorporating fillers to the resin, regardless of the type of filler, is to optimising the properties 
and performance of the final restorative material. The addition of fillers can enhance the 
mechanical properties of composites, reduce the polymerisation shrinkage, modify the 
thermal expansion coefficient of the composite to match that of the tooth, improve handling, 
provide radio-opacity and provide the composites with wear resistance and translucency.162 
Conventional composites contain a range of fillers including silica, quartz and radiopaque 
silicate particles based on the oxides of barium, strontium, zinc, aluminium and zirconium.163 
A widely accepted classification based on filler particle size was proposed by Lutz and 
Phillips, where composites are distinguished as macro-filler composites (0.1-100 µm), micro-
filler composites (0.04-0.1 µm) and hybrid composites (fillers of different sizes).164 However, 
resin-based composites can be classified either according to their composition or the filler 
particle size.165  
Most of the current conventional composites have a filler particle size in the range of 
0.04-0.7 µm. The concern is that particles of these sizes cannot interact optimally with the 
nanoscopic (1-10 nm) structural elements of enamel and dentine, such as the enamel rods, 
HA crystals, dentinal tubules and collagen fibres.166 As a result, the adhesion between the 
restorative material and the tissue can be compromised. However, the manufacturing of new 
advanced composites with unique properties became possible with the introduction of nano-
fillers (particle size 1-100 nm, Table 2). The smaller particle size causes less curing shrinkage, 
offers more uniform particle distribution, allows a higher filler load, reduces viscosity and 
offers better handling, while the mechanical properties remain sufficiently competent.166 The 
average filler size in nanocomposites is 40 nm, but this is not a breakthrough as the same 
filler size had been achieved with the so called “micro-filled composites” since the 70’s. The 
real innovation with nano-fillers is their ability to increase the load of the inorganic phase. 
Micro-filled composites have a 50 wt. % filler load compared to 80 wt. % for the nano-
filled.167 Filtek Supreme (3M ESPE, St. Paul, MN, USA) was the first dental nanocomposite 
to be launched in the market in 2002. Other examples of commercially available 
nanocomposites are Premise (Kerr/Sybron, Orange, CA, USA), GrandiO (Voco, Cuxhaven, 
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Germany), Ceram-X (Dentsply DeTrey, Konstanz, Germany), 4 Seasons (Ivoclar Vivadent, 
Schaan, Liechtenstein) and Palfique (Tokuyama Dental Corp., Tokyo, Japan). 
Adding nano-fillers to enhance the physical and mechanical properties of resin-based 
composites is advantageous, and incorporating the highest possible percentage of filler 
content is the ultimate aim. However, the maximum filler load should be carefully considered 
because there are limitations. Table 2 shows that the effect of nano-fillers on the mechanical 
properties on the composites has received special attention. Some of the mechanical 
properties commonly measured include microtensile bond strength, flexular strength, 
diametral tensile strength, fracture toughness, microshear bond strength, Vickers hardness, 
and compressive strength.  
Lohbauer et al. found that elevating the concentration of zirconia nano-fillers in either 
the primer or the adhesive gradually increased the microtensile bond strength.168 Although 
the highest values were reported for 20 wt. % filler content, even specimens with a low filler 
profile (5 wt. %) had enhanced mechanical properties compared to the unfilled controls. 
Other research groups have also reported that composites had better mechanical properties 
when they contained nano-fillers at a higher concentration.169-172 However, there does appear 
to be an optimal maximum of the percentage of nano-filler in the nanocomposite, after which 
the mechanical properties do not improve further, or even deteriorate. In some cases, the 
mechanical performance declined to such an extent that the unfilled controls were 
superior.169,171,173 The optimal filler load varies significantly between materials, and was 
about 10 wt. % for CaF2, 0.2 wt. % for HA, 0.5 wt. % for sodium montmorillonite (Na-MMT) 
and 40% for silica nano-fillers (Table 2).169-172 However, some caution should be used when 
comparing the optimum filler load across ENMs because the studies so far have not used 
standardised methodologies to prepare the composites; each necessarily requiring a different 
NPs synthesis, types of resin, modifications of the particle surface, and the timing of the 
polymerisation process. Nano-filled composites may not always enhanced mechanical 
properties compared to micro-filled composites. Ruttermann et al. found that solubility and 
shrinkage were similar for both types of composites, but the nano-filled composites 
demonstrated higher water sorption and opacity.174  
Although spherical nano-fillers are popular, partly because they distribute stress more 
uniformly across the bulk volume of the composite resin and inhibit crack formation;166 
CNTs have also been tried. Zhang et al. synthesised a composite based on single-walled 
carbon nanotubes (SWCNTs).175 The result was a nanocomposite with improved mechanical 
performance. SWCNTs are well-known to have exceptional strength, but they can also be 
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accepted at higher filler concentrations by resin systems due to their unique dimensional 
distribution (aspect ratio > 1000).176 Further research should be encouraged on resins 
accommodating CNTs. 
The aesthetics of the composite is also a critical issue for patients, and for example, 
colour matching with the patients natural teeth is desirable. NPs have been employed to 
modify the translucency for improved aesthetics.177 However, the optical properties are also 
of clinical importance, and nano-fillers have been used to match the radiopacity of dental 
adhesives,178 as well as to reduce the working and setting times for resins.173 Clearly, nano-
fillers can improve some properties while compromising others in the overall nanocomposite. 
The practitioner should therefore take an overview of the composite in the context of clinical 
considerations which are mainly determined by the position of the cavity and the aesthetic 
requirements.163  
 
Dental implants 
The aim of the dental implant manufacturer is to provide a product with a high success rate 
after the initial implantation, and longevity. At present, the failure rates are 5-10%, mainly 
due to poor osseointegration, infection, or rejection.179 The future of a dental implant is 
dictated by the inflammatory response and the behaviour of the tissue at the tissue-implant 
interface in the individual patient. Consequently, the implant surface chemistry and 
topography are fundamental aspects to be considered when designing an implant. Cells are 
typically around 10 µm in diameter, but the cell parts are much smaller, in the sub-micron 
scale. The proteins secreted during osseointegration are even smaller with a typical size of 
just 5 nm; which is close to the dimensions of the smallest man-made NPs.180 The notion of 
ENMs with sizes comparable with basic biological components has been used as an argument 
for the bespoke design of ENMs for medical applications where the material interact with 
cells and tissues at a molecular level with a high degree of specificity.181 In principle, this 
idea also applies to dental implant incorporating nanotechnology. Table 3 shows some 
selected examples of the use of ENMs in dental implant applications. 
Modifying the surface of Ti implants is one way to improve how an implant interacts 
with the surrounding tissues. The application of a thin ceramic layer on metallic implants is a 
popular way to enhance the formation of new bone and avoid adverse inflammatory reactions. 
The ceramic nano-materials selected for manufacturing coatings on Ti implants are those that 
have been classified as bioactive and mainly include HA,182-184 bioactive glass,185 and other 
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calcium phosphate compounds.186,187 Nano-HA is probably the most preferable material used 
as a coating for Ti, Ti alloys and stainless steel implants because it is similar to the inorganic 
component of bone. HA coatings transform implants to a biocompatible substrate that cells 
prefer to adhere to than the metallic surfaces of uncoated implants. In vivo experiments with 
animal models have suggested that Ti implant surfaces modified with HA NPs show 
enhanced bone bonding and accelerated new bone formation.188,189 It has been demonstrated 
that dental implants coated with HA NPs have better bone-to-implant contact and increased 
removal torque values compared to the uncoated controls.190,191 However, the surface 
roughness and chemistry of implants are not the only factors that determine the biological 
responses. It has been suggested that particle size and morphology (e.g., spherical, rod-
shaped, crystals) also play an important role in osteoblast adhesion and their bone-forming 
capacity.192,193  
Implants coated with 20-100 nm calcium phosphate (CaP) nanocrystals have 
demonstrated similar enhanced osseointegrative behaviour in vivo.194,195 In vitro studies 
showed that osteoblasts (but not stem cells) had better proliferation on nano-CaP-
impregnated Ti implants compared to untreated controls.196 However, both cell types 
demonstrated higher differentiation activity on surface-modified specimens. Alumina is 
another nano-ceramic candidate with promising osseointegrative properties. Webster et al. 
reported increased osteoblast proliferation and adhesion on substrates made of nano-sized 
alumina (24 nm).197 Alumina nano-fibres (2 nm in diameter, 50 nm long) have also been 
found to encourage osteoblast differentiation and calcium deposition.198 Yang et al. found 
that smaller particles of nanodiamonds promoted osteoblast adhesion and proliferation more 
compared to larger particles.199 This latter finding could be the basis for manufacturing 
coatings with variable particle sizes to control the degree of bone apposition and favour bone 
growth at specific anatomical locations. Other types of NPs, such as yttrium-stabilised 
zirconia and CNT-CaP NPs (Table 3), have also been investigated as means to reinforce Ti 
alloy and polymer-based implants respectively.189,200  
Numerous in vivo and in vitro studies have suggested that nano-particulate coatings 
render dental implants more biocompatible while facilitating formation of new bone and 
reducing healing time (Table 3). However, a considerable number of scientific reports have 
also shown no significant benefits from modifying implant surfaces with NPs. In vivo studies 
comparing blasted/acid-etched Ti endosseous implants (controls) with specimens further 
subjected to a bioceramic deposition process to form a nano-CaP coating, did not indicate any 
difference in bone bonding or healing between the two groups.201-203 A possible explanation 
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for these results is that the optimal bone quality of the implant bed overshadowed the superior 
oseointegrative properties of the CaP-coated specimens. This may suggest that in vivo studies 
selecting healthy bone tissues as implantation sites do not mimic the poor state of bone in 
edentulous patients. 
Despite extensive research, it is still not clear whether the improved properties of the 
nano-coated implants are derived from the chemistry of the coatings, or whether it is due to 
the change that the coatings introduce to the surface roughness of the implants. Mendes et al. 
argue in favour of the latter suggesting that the improved osseointegration found for implants 
coated with nanocrystalline CaP arises from the complexity of the resultant surface rather 
than the CaP chemistry itself.204 In general, the degree of osseointegration is improved with 
increased surface roughness;205 and nano-modified dental implants do have increased surface 
roughness compared to standard metallic implants with polished surfaces. Consequently, one 
might argue that the advantage of the NPs deposition on the dental implants surfaces is 
mainly due to the nanotopography they introduce. However, further research is required to 
either support or reject this hypothesis. It is noteworthy that many studies in the current 
literature fail to fully characterise the implant surfaces under investigation and in some cases 
scanning electron microscopy (SEM) is the only technique employed to describe these 
surfaces and compare between them. Thus, future studies should include more advanced 
surface characterisation techniques (e.g., 3D measurements for SEM, atomic force 
microscopy, X-ray photoelectron spectroscopy)  to assess the nanostructure of coated 
implants and provide quantitative data which then could offer a better understanding on 
whether the bone response is determined by the surface nanotopography.206,207 Also, further 
investigation is needed on how the particle size and morphology affects the host response, 
and ultimately the bone bonding. 
 
Dentifrices – Personal care products 
The use of dentifrices (toothpastes, tooth powders, mouthwashes, etc.,) to manage oral health 
and generally help prevent dental caries is recommended to the public. The use of 
nanotechnology in these products is of growing commercial interest. In principle, ENMs 
could be used to aid the mineralisation process of the enamel and/or dentine (discussed above 
by providing HA, fluoride), control microbes and plaque as part of brushing (e.g., 
antimicrobial ENMs, Table 1), or provide nanoscale minerals to enhance pH control (e.g., 
calcium phosphate). Employing artificial HA in dentifrices, such as toothpastes, to restore the 
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lost mineral content of enamel and dentine has been considered as a sensible strategy.208-211 
Nano-HA has been tested in different forms (spherical, needle-like, crystalline). Lu et al. 
found that nano-HA added in toothpaste, not only enhanced the micro-hardness of enamel 
and improved remineralisation but may also reduce bacterial colonisation of the tooth 
surfaces.209 Other ENMs that have been suggested to promote enamel and dentine 
remineralisation in experimental studies include nano-particulate bioactive glass,212,213 nano-
sized carbonated apatite alone or in combination with silica,214,215 nano-sized calcium 
fluoride,216 carbonate-hydroxyapatite nanocrystals217 and nano-precursors of amorphous 
calcium phosphates.100 Logically, these materials might also be included in toothpastes or 
other commercial dentifrices. 
Nonetheless, there are some commercial products where the basis for mode of action 
has been explained. Casein phosphopeptide (CPP), which is produced from a tryptic digest of 
casein by aggregation with calcium phosphate and purification by ultrafiltration,218 carries 
calcium and phosphate ions bound to it in the form of amorphous calcium phosphate (ACP). 
The CPP-ACP nanocomplex is commercially known as Recaldent™ and is available as a 
product with the brand name GC Tooth Mousse® (GC Ltd) in the form of a topical cream. As 
a rich source of calcium and phosphate ions, the CPP-ACP nanocomplexes have been 
suggested to promote enamel remineralisation. When in the oral cavity, the CPP-ACP 
nanocomplexes adhere to the enamel, pellicle, plaque and soft tissue, delivering calcium and 
phosphate ions. The free calcium and phosphate ions then enter the enamel rods and reform 
into apatite crystals, contributing to the teeth remineralisation.  
The role of nano-HA and other Ca-based NPs has been investigated as a treatment for 
dentine hypersensitivity by occluding the dentinal tubules.98,219 Application of 40 nm silica 
NPs has also been found to form a physical barrier at the entrance of dental tubules 
preventing the movement of the fluid within the tubules which is the cause of sensitivity 
problems.99 Strontium chloride was the first tubule blocking agent to be introduced to the 
market (as Sensodyne) 50 years ago.220 However, strontium chloride was incompatible with 
fluoride and was finally replaced with strontium acetate. Although several studies have 
shown that 10% strontium chloride dentifrices reduce dentine hypersensitivity,221-223 Zappa, 
who summarised the results of clinical studies with strontium chloride toothpastes, concluded 
that the clinical efficacy of strontium-based products was uncertain.224 Saliva naturally plugs 
the dentinal tubules both by transporting calcium and phosphate ions into the openings of the 
channels and by forming a calcium and phosphate-rich salivary glycoprotein layer.225 In an 
attempt to mimic the natural occlusion mechanism, ProClude (Ortek Therapeutics Inc.) was 
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manufactured. ProClude consists of arginine (an amino acid which is positively charged at 
physiological pH), bicarbonate (a pH buffer) and calcium carbonate (as a source of calcium). 
Arginine binds to the surface of calcium carbonate and in the form of positively charged 
agglomerates adheres to the negatively charged dentine surface and tubules.226 Colgate 
developed the arginine technology (Pro-ArginTM) further by adding fluoride.227 However, it 
has to be noted that a number of studies have shown that brushing with toothpastes for 
sensitive teeth has an adverse effect causing dentine erosion and the tubules to open rather 
than resolving the problem.228 Clearly, there is an emerging market on the use of 
nanotechnology in dental healthcare products, and like other ENMs applications in the food 
or personal care sectors, the safety and efficacy of these products need to be proven, as well 
as improved product labelling to give clarity on which products actually contain natural or 
ENMs (see below).    
 
Safety of engineered nanomaterials used in dentistry 
The safety of patients 
The current regulatory procedures for approving new medicines and medical devices and how 
they apply to ENMs has recently been discussed,158 as well as considerations for occupational 
health.21,229 Briefly, the overarching process of conducting a clinical trial with a medicine 
intended for human use is covered by the Clinical Trials Directive (Directive 2001/20/EC) 
which sets out the implementation of good clinical practice for such trials, and various codes 
relating to medicinal products for humans (e.g., Directive 2004/27/EC). In addition, 
regulation EC number 726/2004 lays down the procedure for the authorization and 
supervision of medicinal products and this involved establishing the European Medicines 
Agency with some oversight of national level authorities within Europe (Regulation (EC) No 
26/2004). Juillerat-Jeanneret et al. argue that from a legal and regulatory perspective that 
these regulations apply equally to nanomedicines, as the fundamental purpose of the 
regulations is the same for all medicines.158 Outside the European Union, regulations are 
often established at national level. For example, in the United States the Food and Drug 
Administration (FDA) provides federal regulations on the safety of medicines (e.g., Federal 
Regulations 21). The founding principles behind regulation include demonstrating that the 
new product is effective for its intended clinical use, or more effective than an existing 
product, and it must be safe.158 In the case of dentistry, Annex I of the Medical Devices 
Directive 93/42/EC identifies some legal requirements on the use of devices that would 
Page 24 of 61
ACS Paragon Plus Environment
ACS Nano
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
24 
 
include dentures and various dental implants, whether or not they contained ENMs. The 
multi-variate use of different ENMs in composites, or to restore dentine, presents some 
complexity for the regulations since one of the drivers is the intended use of the new 
substance. For example, the use of Ag NPs as an antibacterial in a composite might be 
regarded as a medicine, while the inclusion of (for example) CNTs or HA for mechanical 
properties might fall under the medical devices regulations. Some clarity on these points is 
needed from governments and regulatory authorities, but it would seem sensible for 
commercial companies seeking product approval to be guided by the main intended use of the 
whole product as a starting point.  
In essence, risk is a function of exposure and hazard (toxicity), and both aspects are 
considered in risk assessments for ENMs.21 For patients the exposure is defined by the 
intended treatment, the physical form, and concentrations of the ENMs in the therapeutic 
agent or medical device. Since the intended treatment (exposure) is usually known from the 
outset, although some investigations of erosion and bioavailability of ENMs from dental 
materials may be needed, the focus is mainly on hazard assessment. The regulations for 
toxicity testing also require that the route of uptake, frequency of dosing, formulation, 
concentration, and administration site must be related to the expected use in humans. 
Consequently, for medicines used in dentistry, oral toxicity tests on animal models will be 
relevant; as well as toxicity data on the tissues relevant to the oral cavity. 
There are several theoretical routes of exposure for dental patients. These include: (i) 
accidental or incidental ingestion of the nano-containing dental material during or after 
treatment; (ii) the generation of aerosols during dental treatment that might present a 
respiratory hazard to the patient (e.g., aerosols from drilling into a nano-composite during a 
dental repair); (iii) systemic toxicity from any ingested or inhaled ENMs; (iv) direct toxicity 
to the cells/tissue of the oral cavity.  
The ingestion and subsequent systemic hazard from oral exposure to ENMs has been 
studied in rodents (TiO2;230,231 Cu NPs;232 Ag NPs19) and fish (TiO2;233 C60 and CNTs234), as 
well as in vitro using the Caco-2 intestinal cell line235,236 or isolated perfused intestines.35 
Selected examples of oral toxicity studies with different models are summarised in Table 5. It 
is clear that some pristine (unmodified) ENMs can be absorbed across the vertebrate gut from 
an ingested food matrix (e.g., TiO2233), and although for metal-containing ENMs the 
bioavailability may only be a few percent of the dose, this is not dissimilar to traditional 
dissolved metal of concern like mercury.233 However, most oral toxicity studies in animal 
models have used gut gavage,232 and there is some concern that ENMs introduced to the gut 
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via salines may have a higher bioavailability than those in a food or dental material matrix. 
Nonetheless, the use of physiological saline would also be relevant to dental practice.  
In vivo studies on rodents show that at least total metal concentrations in the internal 
organs from exposure to metal-containing ENMs can increase, and this may also lead to 
organ pathology (Table 5). For example, Wang et al. found pathology in liver and kidney of 
mice after single oral gavage of TiO2 NPs (25 or 80 nm).231 There is also at least one report of 
argyria in humans after chronic ingestion of colloidal silver solution, indicating that silver 
from nano-silver can be absorbed.237 However, there is controversy over whether or not intact 
particles are absorbed across the gut epithelium. Gitrowski et al. recently demonstrated 
endocytosis of intact TiO2 NPs by Caco-2 cells.236 Interestingly, the uptake mechanism was 
sensitive to endocytosis inhibitors such as nystatin and was also dependent on the crystal 
structure of the material; indicating that shape/crystal form is also an important aspect of the 
oral hazard. 
The hazard from dental materials must be taken in context with these studies on oral 
toxicity to animals, and other oral hazards outside of dentistry for the patient as a member of 
the public. For example, there is a potential dietary exposure risk from food and personal care 
products containing ENMs.10,12,238 In addition, the mucociliary escalator in the lung may clear 
ultrafine particles (e.g., from air pollution) from the airway which are then subsequently 
ingested. The relative oral exposure from ENMs during intermittent dental work may be 
small compared to the potential long term exposure via the food. For example, Weir et al. 
estimate ingestion of about 1-3 mg TiO2 Kg body weight-1 day-1, with about a third of the 
material being at the nanoscale.12 A patient would therefore need to ingest grams of TiO2 
ENM on a visit to the dentist in order to achieve the same annual dose as might be 
incidentally achieved from food products.  
However, the toxicity data in the public domain on ENMs used specifically in dental 
applications is sparse, with no information on oral toxicity from dental materials, biomaterials 
or implants containing ENMs in animal models or patients. As a rule, dental materials for 
permanent restorations are designed to be inert and chemically stable in the oral environment. 
However, there has always been a concern that leaching of toxic compounds may occur either 
as a result of material instability or degradation, or due to inappropriate application or 
preparation of the dental material by the clinician. Metal release from dental materials is not 
uncommon (e.g., amalgams, metal alloys239), but the reported elemental release is usually 
negligible or comparable to that of food and drink intake. The release of chemical substances 
leaching from resin composites240,241 and endodontic sealers242,243 has also been confirmed; 
Page 26 of 61
ACS Paragon Plus Environment
ACS Nano
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
26 
 
raising the concern that patients are unnecessarily exposed to potentially toxic chemicals 
during and after treatment. However, similar information for dental materials containing 
ENMs is lacking. 
There is also a concern of direct contact toxicity from the ENM with the cells and 
tissues of the oral cavity. The oral epithelium is mostly non-keratinised stratified squamous 
epithelium, with the exception of gingiva, hard palate and dorsal surface of the tongue. The 
epithelium acts with saliva to form a protective mucous barrier. The salivary film covering 
the oral cavity has an estimated thickness of 70-100 µm,244 whereas the thickness of the non-
keratinised squamous epithelium varies between 500 and 800 µm;245 the latter being thicker 
than the epithelium of the oesophagus (300-500 µm246) or the intestines (20-25 µm247). It 
therefore might be argued that the oral cavity is a better barrier than, for example, the more 
permeable intestine, but this notion derived from the transport of solutes across epithelia has 
yet to be verified with experimental data for ENMs.248 It seems likely that some types of 
ENMs will become trapped in the mucous secretion of the saliva by steric hindrance 
(discussed above), but nanomedicines are being engineered to cross mucous barriers (e.g., to 
improve drug delivery249) and it is possible that such traits will be useful in dentistry (e.g., 
delivery of antimicrobials, anaesthetics, etc.,).  However, there is a concern that some ENMs 
are immunogenic250 and would induce a hypersensitivity reaction or inflammation in a 
vulnerable patient. This risk may be present with traditional medicines and medical devices, 
and whether the risk would be greater for an ENM in the oral cavity is unknown. 
 
Occupation exposure of the practitioner 
The occupational health of the practitioner should also be considered in the context of routes 
of exposure. For health and safety in the workplace, safe systems of work are aimed at 
preventing exposure so that there is a negligible risk. This approach also applies to 
ENMs,20,21,251 although in practice employers do show some uncertainty about what might be 
nano-specific in the governance of health and safety.252 Potential exposure of the practitioner 
could arise from incidental ingestion or dermal contact. However, the clinical practice of 
wearing surgical gloves, and not eating or drinking while treating patients should minimise 
these exposure routes as they would with other substances.  
Exposure to aerosols of dental materials containing ENMs has not been quantified in 
a workplace scenario, and there is a theoretical exposure from activities such as drilling or 
filing into a repair that already contains ENMs.  There are exposure limits set for dusts and 
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powders that might create an aerosol in the workplace (e.g., 10 mg m-3 for an 8 h exposure to 
dust generally in the UK), and reports from various health and safety agencies indicate 
exposures of a few mg m-3 or less to workers in ENM manufacturing plants.253 The exposure 
risk to dentists working with only a few grams of dental material at a time is likely, therefore, 
to be much less. Interestingly, studies on abrasion/sanding of industrial coatings and 
composites find mainly negligible (not detectable) or low releases of free ENMs.254 This 
might imply that a similar activity by a dentist such as abrading/shaping a dental composite 
might be low risk. However, distance from the point source of the exposure is also critical, 
and in dentistry the practitioner is inevitably very close to the patient. Clearly, further 
research is needed on workplace exposure to ENMs in dentistry. 
 
Conclusions and recommendations 
There appears to be many potential benefits to patient outcome from using nanotechnology in 
dentistry. The benefits include new materials for preventative health care using dentifrices 
that are either antimicrobial and/or have some restorative properties for the enamel. The use 
of ENMs to enhance the mechanical and physiological functions of the tooth via new nano-
fillers and composites should provide an enhanced capability for some areas of restorative 
dentistry. The use of ENMs to improve osseointegration, infection control, and 
biocompatibility of dental implants may reduce the rejection rates in some invasive 
procedures. There are also completely new frontiers in dental treatment such as the use of 
ENMs to control and direct pulp stem cells in order to regenerate the tooth.   
These potential benefits should be balanced against the risks. For the patient the exposure 
to ENMs will be controlled by the planned dental treatment, and thus the main concern is on 
the hazard of the ENMs in dental materials. The data so far indicates that oral toxicity for 
ENMs is low, but some ENMs are translocated across the gut to cause systemic disturbances, 
perhaps with organ pathology. However, the matrix in which the ENM is incorporated will be 
important and oral toxicity studies have yet to be done with dental materials containing 
EMNs. Overall, however, the information so far indicates that the oral hazard is low or 
manageable and should not be a barrier to the safe innovation of nanotechnology in dentistry. 
The safety assessment processes in place for medicines and medical devices remain robust, 
and although individual toxicity tests may need modifications to work well with ENMs, the 
overall safety strategy is appropriate. Nonetheless, there are some improvements in health 
and safety that can be made. For example, better guidance to practitioners on nano-
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incorporated products with respect to patient safety and occupational health. For the public 
and patients, the nano-specific labelling on the many personal care products in dentistry could 
be improved to clearly identify the nano ingredient(s). Thus giving clarity on whether a 
product actually contains an ENM and what the proposed mode of action or benefit of the 
new product might be to the consumer.  
 
Research recommendations and data gaps. 
Although the potential benefits appear to outweigh the risks associated with using ENMs in 
dentistry, there are still several areas where knowledge can be improved. These include:  
(i) Specific research to understand how the protein corona is formed on ENMs in 
saliva, and how the ENM might change the bioavailability of active ingredients in 
the saliva. It is also unclear how or if ENMs alter the secretory functions of the 
salivary glands. 
(ii) Research on clinically-relevant biofilms. Although there is some understanding of 
laboratory cultures of microbes and ecologically-relevant biofilms. In contrast, 
biofilms in/on the human body are poorly understood with respect to ENMs. 
Some targeted research on the oral cavity biofilm is needed to underpin the role of 
ENMs in drug delivery, antimicrobial functions, and on penetration to the dentine 
surface. 
(iii) Mechanistic investigations on how ENMs strengthen the tooth structure (enamel, 
dentine, pulp and cementum) and further exploration of adding physiological 
function to nano-enhanced dental materials. The use of second and third 
generation ENMs with complex three dimensional structures rather than particles 
need to be explored for their mechanical properties in dental applications. 
(iv) The use of ENMs in dental therapeutics for drug delivery and to provide growth 
factors involved in tissue regeneration, or stem cell treatments is worthy of more 
investigation with respect to both efficacy and safety. 
(v) New dentifrices containing ENMs offers the chance of preventative dentistry and 
better public health, but consumer choice is important. Research on the 
composition of existing products, and product labelling, are part of improving 
consumer confidence in using commercial products containing nanotechnology. 
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Figure legends 
Figure 1. A. Diagram shows the presence of NPs (isolated particles or agglomerates) in saliva 
and the structure of dentinal tissues. The pellicle covers the superficial layer of enamel and 
the oral biofilm develops on the pellicle surface. The characteristic hexagonal shape of the 
enamel crystallites is apparent and also the presence of the tubules in the underlying tissue of 
dentine. The NP-ion-protein complexes do not adhere directly to the tooth surfaces, but 
adhesion occurs either to the pellicle layer or the developing biofilm. 
B. Schematic diagram of the oral environment, oral biofilm and dentinal mineralised tissues 
showing the distribution of NPs and ions. Natural saliva normally contains a range of ions 
and proteins. In the presence of NPs, NP-ion-protein complexes are formed.  Oral conditions 
promote particle agglomeration that results in particle sedimentation onto the dentinal 
surfaces. The pellicle has a globular structure and its proteinaceous layer facilitates the 
adherence of the early colonising species necessary for the oral biofilm development. The 
oral biofilm and pellicle act as a diffusion/permeation barriers to NPs preventing them from 
reaching the enamel-pellicle interface. Certain ions (F-, Cl-, SiO44-, Zn2+) are more abundant 
near the external surface of enamel, while others (Na+, Mg2+, CO32-) are found at higher 
concentrations near the dentino-enamel junction. The most commonly ions found in dentine 
are F-, Na+, Mg2+ and CO32-.  
 
Figure 2. Tooth anatomy showing the four main components of the tooth (enamel, dentine, 
cementum and pulp). Details of the complex oral biofilm, which develops on the tooth 
surfaces, and the characteristic microscopic channels (dentinal tubules) that permeate dentine 
are also shown. Dental research studies have investigated the use of a big range of ENMs in 
different clinical applications including enamel remineralisation strategies, antibacterial 
applications, caries management, dentine hypersensitivity and root canal disinfection.  
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Table 1. Use of antimicrobial engineered nanomaterials in dental materials. 
Nanomaterial 
characteristics Aim of application Treatment Key results Author 
Chitosan (CS) functionalised with 
rose-bengal (RB) NPs were 
synthesised from CS NPs that were 
chemically crosslinked to RB 
using N-ethyl-N’-(3-dimethyl 
aminopropyl) carbodiimide (EDC 
5 mM) and N-hydroxysuccinimide 
(NHS 5 mM). The particle size of the 
resulting CSRB NPs was 60 ± 20 nm.  
To introduce an 
antibiofilm effect and 
stabilise the structural-
integrity of dental root 
dentin by 
photocrosslinking 
dentine collagen matrix. 
An E. faecalis biofilm was left to mature for 21 days 
before being challenged with CSRB NPs (0.1 and 0.3 
mg ml-1) or RB (10 µM) for 15 min and exposed to 
photodynamic therapy (dosage of  20, 40 and 60 J cm-
2; and fractionated dosage of 10 and 20 J cm-2 twice). 
The cytotoxicity tests were performed using mouse 
fibroblast cells. Incubation time after exposure was 
15 min in the dark. CSRB NPs and RB were tested 
with radiation (20 J cm-2) and without radiation.     
Complete death of biofilm bacteria was not achieved with either CSRB 
or RB even at 60 J cm-2. The best antibacterial effect was achieved with 
fractionation of the dosage (20 + 20 J cm-2) with complete elimination 
of biofilm bacteria in the case of 0.3 mg ml-1 CSRB NPs. The initial 
thickness of the biofilm was 39.2 ± 7.3 µm, which was reduced to 13.1 
± 4.3µm and 23.1 ± 5.57 µm after CSRB NPs and RB treatment 
respectively. CSRB NPs showed no dark toxicity (95.5 ± 12% cell 
survival), but toxicity was higher following irradiation (72.86 ± 9% cell 
survival).  
Shrestha et al. 
(2014)255 
50 nm ZnO NPs and 20 nm Ag NPs Resin composite with 
antibacterial activity to 
inhibit the growth of oral 
cavity microorganisms. 
ZnO or Ag NPs were added to a resin composite 
material at a concentration of 1 wt. %. Disk-shaped 
specimens were prepared using light treatment. The 
antibacterial activity was tested against S. mutans and 
Lactobacillus after 12 h of incubation.     
Measurement of the active colonies formed on the surface of blood 
agar plates showed a significant antibacterial activity for the resin 
composites with added ZnO NPs (0.93 ± 1.53 CFU for S. mutans and 
1.20 ± 0.77 CFU for Lactobacillus) or added Ag NPs (7.33 ± 7.19 and   
0.73 ± 0.79 CFU respectively) compared to the control group (126.0 ± 
29.47  and 3.80 ± 2.54 CFU respectively).     
Kasraei et al. 
(2014)256 
2.7 nm Ag NPs. Ag NPs were 
synthesised by dissolving silver 2-
ethylhexanoate powder in 2-(tert-
butylamino)ethyl methacrylate 
(TBAEMA) at 0.1 g of silver salt per 
0.9 g of TBAEMA. 
An adhesive/primer 
system with improved 
antibacterial activity. 
5% of aquaternary ammonium monomer 
(dimethylaminododecyl methacrylate, DMADDM) 
and 0.1% of Ag NPs were incorporated into a primer 
and an adhesive. 
The agar disk diffusion test showed that primer specimens containing 
0.1% Ag NPs had significantly larger inhibitions zones compared to 
controls. The MTT assay and lactic acid production results showed that 
the metabolic activity of bacteria on specimens containing Ag NPs was 
significantly lower. The colony forming unit (CFU) value for the 
DMADDM + Ag NPs specimens was 107 compared to 0.4 x 109 for the 
controls without Ag NPs.   
Cheng et al. 
(2013)257 
Colloidal solution of lactose-modified 
chitosan (Chitlac) - Ag NPs. Ag NPs 
were obtained from AgNO3 after 
mixing with ascorbic acid. Size of 
Chitlac - Ag NPs clusters was 1-5 
µm. 
Antimicrobial coating 
for medical devices and 
implants. 
Thermoset surfaces were coated with 0.5 mΜ Chitlac 
- Ag NPs. Antibacterial activity was tested against S. 
aureus and P.  aeruginosa (3h). Cytotoxicity tests 
were performed using human skin fibroblasts and 
osteoblast-like cells (24-72 h). 
Viability of bacteria after exposure to treated surfaces was 6 times less 
(1 log (CFU ml-1) compared to untreated surfaces (6 log (CFU ml-1). 
LDH release after 72 h contact with treated surfaces was 15% for 
fibroblasts (control was 21%) and 8% for osteoblast-like cells (control 
was 9%). 
Travan et al. 
(2011)140  
Quaternary ammonium 
polyethylenimine (QPEI) NPs were 
added in a resin composite containing 
47% zirconia-silica particles with 
average size 0.01-6.0 µm. Size of 
QPEI not given. Components were 
manually mixed for 20 s. 
Resin composite with 
antibacterial activity. 
Disc-shaped control composites and composites with 
1 wt. % QPEI NPs were placed intraorally in patients. 
Biofilm formation was allowed for 4h before testing.   
71% of bacteria remained viable on control resin composite compared 
to 19% on samples containing QPEI NPs. Incorporation of QPEI NPs 
increased the biofilm thickness to 107 µm (was 69 µm on control 
surfaces).    
Beyth et al. 
(2010)151 
QPEI NPs were incorporated into a Provisional restorations QPEI NPS were introduced to the restoration material No bacterial growth was observed for the 24 h aged samples. No Shvero et al. 
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commercial provisional cement. Size 
of the NPs was not provided. 
with long-term 
antibacterial effect. 
at 0.5, 1 and 2 wt. %. Microtiter plates were coated 
with the final product and the antibacterial effect of 
24 h and 14 days aged samples was tested against S. 
mutans and E. faecalis.   
growth of S. mutans was observed on samples aged for 14 days. No 
growth of E. faecalis was also observed on 14 days aged samples 
where the QPEI NPs concentration was higher than 1wt. %.  
(2010)152 
Sol-gel derived bioactive glass 
nanopowders (58S, 63S, 72S). 
Particle size was 20-90 nm. 
Orthopaedic infection 
control and disinfection 
of root canal. 
Bacteria (E.coli, S. aureus, S, typhi, P. aeuginosa) 
were cultured in broth containing bioactive glass NPs 
at different concentrations (6.25 – 100 mg ml-1) for 
24, 48, 72, 96 and 120 h. Cytotoxicity was assessed 
by the MTT assay using mouse fibroblasts. 
The minimum bactericidal concentration (MBC) of 58S was 50 mg ml-1 
against E. coli and S. aureus and 100 mg ml-1 for S. typhi and P. 
aeruginosa. MBC of 63S was recorded at 100 mg ml-1 for E. coli and S. 
aureus but had no effect on S. typhi and P. aeruginosa. 72S showed no 
bacterial effect. At 72 h, 63S was not statistically different from the 
control, but 58S and 72S showed greater cell viability and proliferation.  
Mortazavi et 
al. (2010)150 
40-100 nm ZnO NPs and 30 nm TiO2 
NPs. 
Resin composites with 
antimicrobial activity to 
prevent biofilm 
formation. 
ZnO NPs were introduced to a microhybrid 
composite at 1, 5 and 10 wt. %. Also 10% ZnO or 
TiO2 NPs were added to a nanofilled composite. 
Antibacterial activity was tested against S. sobrinus 
after 3 days of biofilm formation. 
Minimum inhibitory concentration (MIC) of ZnO NPs was 50 µg ml-1 
whereas the MBC was 150 µg ml-1. There was a 20% reduction in 
biofilm growth on composite discs containing 10% ZnO. Antibacterial 
effect on discs with 10% TiO2 was similar to controls.    
Aydin and 
Hanley 
(2010)143 
TiO2 NPs (25-85 nm). Anatase to 
rutile phase was 3:1.  
Dental adhesives with 
long term bacteria 
inhibition properties. 
TiO2 NPs were added to a commercial dental 
adhesive at 5, 10, 20 and 30 wt. %. The nano-
adhesive was then spread on a 1.2 cm2 disc and light 
cured. Samples were coated with S. epidermidis and 
UV irradiated for up to 120 min.  
Bacteria harvested from the specimens containing 20% TiO2 NPs 
produced 12 colonies per sample, while 10% containing samples only 1 
colony. The incorporation of 20% TiO2 NPs did not increase the tensile 
bond strength of specimens (18 N) compared to control. 
Welch et al. 
(2010)124 
Nanometric bioactive glass 45S5 
prepared by flame spray synthesis 
(particle size was not given) and also 
micrometric 45S5 bioactive glass 
(particles < 5µm). 
Root canal disinfectant. Caries and restoration free human premolars were 
seeded with 0.1 ml E. faecalis and then root canals 
were filled with nano-45S5, micro-45S5 or a 50:50 
mixture of both. 
Nano-45S5 had a 12-fold higher surface area compared to its 
micrometric counterpart. All specimens treated with nano-45S5 showed 
bacterial growth (12 out of 12), while micro-45S5 was significantly 
more effective (1 out of 12). Three out of 12 specimens dressed with 
the nano-micro mixture showed bacterial growth. 
Waltimo et al. 
(2009)258 
Ag NPs (particle size < 5 nm). Composite adhesive with 
antibacterial activity to 
prevent enamel 
demineralisation. 
Ag NPs were added to the adhesive at 0, 250 and 500 
ppm. Disk-shaped (3 x 2 mm) specimens were 
prepared and their effect was determined on the 
bacterial growth on liquid media (incubation time up 
to 24 h at 37 oC) and with agar diffusion assay 
(incubation time 48 h at 37 oC). S. mutans and S. 
sobrinus were the bacterial strains tested. 
After 24 h of incubation, the bacterial growth was measured 
spectrophotometrically (A660) and the optical density values for 
specimens containing 0, 250 and 500 mg l-1 Ag NPs were 0.70 ± 0.07, 
0.72 ± 0.06 and 0.69 ± 0.05 respectively in the case of S. mutans. The 
corresponding values for S. sobrinus were 0.70 ± 0.05, 0.68 ± 0.10 and 
0.71 ± 0.11. The values for blanks were 0.7 3± 0.07 (S. mutans) and 
0.70 ± 0.05 (S. sobrinus). The agar diffusion assay showed no zones of 
inhibition. 
Ahn et al. 
(2009)137 
Ag NPs (100-120 nm). An aqueous 
Ag sol was synthesised from a water 
solution of 10 mmol l-1 AgNO3 and 
2% PVP. The solution was deaerated 
with argon gas for 1 h and treated 
with 20 KGy 60Co gamma-radiation.  
Oral tissue conditioner 
with antimicrobial 
activity. 
Disc samples of 20 x 3 mm of tissue conditioner 
containing Ag NPs at 0.1, 0.5, 1.0, 2.0 and 3.0% 
(vol/vol %: Ag sol/conditioner liquid) were prepared. 
Specimens were placed in culture plates and their 
antibacterial activity was tested against S. mutans, C. 
albicans and S. aureus after 24 and 72 h of incubation 
at 37oC.  
An inhibitory effect was observed against all bacterial strains even for 
specimens with the lowest (0.1 %) Ag content. For S. mutans, C. 
albicans and S. aureus, no CFUs were observed for specimens 
containing 1, 2 and 1% Ag respectively. There were no statistical 
differences between incubation times of 24 and 72 h.    
Nam (2011)139 
Ag NPs (Particle size not specified).  As an antimicrobial A TaN-Ag nanocomposite coating (1.4-1.7 µm thick) The highest relative fluorescence intensity of the bacterial retention was Huang et al. 
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coating for dental 
implants. 
was synthesised by a twin-gun reactive magnetron 
sputtering and deposited on 50 mm pure Ti plate 
specimens. The samples tested contained 0, 14.9, 17.5 
and 21.4% Ag. Control Ti samples were uncoated. 
The antimicrobial efficacy of the specimens was 
evaluated using S. aureus. Samples were inoculated 
with bacteria and incubated for 6 h at 37 oC.  
observed on the uncoated Ti surfaces (97 ± 3 arbitrary units) followed 
by TaN-Ag14.9% (92 ± 2), TaN-Ag17.5% (84 ± 4), TaN (69 ± 3) and 
TaN-Ag21.4% (57 ± 3). The S. aureus growth on uncoated Ti samples 
was 44 CFU cm-2, 37 CFU cm-2 on TaN coated samples and  3 CFU 
cm-2 on TaN-Ag 21.4% coated samples.   
(2010)138 
MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Studies are presented in chronological order for convenience. 
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Table 2. Use of engineered nanomaterials as fillers in dental composite applications. 
Nanomaterial 
characteristics Aim of application Treatment Key results Author 
Hybrid silica/acrylic NPs were 
synthesised by seeded 
emulsion polymerisation. 
Following methyl methacrylate 
(MMA) polymeralisation, a 
poly(methylmethacrylate) (PMMA) 
shell (3-6 nm thick) was formed on 
the surface of silica NPs. Core NPs 
had a diameter size of 59.4 ± 14.4 
nm, whereas hybrid NPs were 
larger (silica/PMMA 78/22: D = 
75.8 ± 12.5 nm; 57/43:  D = 81.2 ± 
15.4 nm).        
As nanofillers to 
increase the silica filler 
content in dental resin 
composites. 
The silica or hybrid (silica/PMMA at 
ratios of 78/22 and 57/43) NPs were 
introduced to the resin and were mixed 
manually until the powder was completely 
wetted. The filler content in the specimens 
prepared was 20, 30 or 40 wt. % for the 
silica NPs and 40, 50 or 60 wt. % for the 
hybrid NPs.  
Composites containing 30 wt. % silica NPs demonstrated the highest 
flexular strength (57 MPa), which decreased with further increase of 
the filler content (48 MPa for 40 wt. %). The flexular strength of 
composites prepared with hybrid NPs at the same filler content (40 
wt. %) was considerably lower (25 MPa for the 78/22 NPs and 30 
MPa for the 57/43 NPs). The flexular modulus of composites 
containing 40 wt. % silica NPs was 3091 MPa and the respective 
value for composites carrying hybrid 78/22 NPs at the same filler 
content was 2694 MPa. The flexular modulus for composites with 
filler particles carrying a higher amount of PMMA (57/43) was 
significantly lower (1528 MPa). The use of hybrid NPs enabled the 
incorporation of a higher concentration of silica in the composites 
and better dispersion of the filler particles.  
Canché-
Escamilla et 
al. (2014)259 
HA NPs (20-70 nm) were prepared 
following biomimetic and 
hydrothermal processes. 
As nanofillers to 
reinforce an adhesive 
system. 
HA NPs were incorporated into the resin 
solutions of the adhesive system at 0.2%, 
1%, 5%, and 10% (w/v). Fillers were 
mechanically stirred with the resins and 
sonicated for 30 min to ensure dispersion. 
The control group had a mean microtensile bond strength (µΤBS) of 
52.1 ± 16.6 MPa, which increased significantly for the adhesive 
containing 1% of the biomimetic HA NPs (59.5 ± 11.9 MPa). The 
µTBS for 10% filler content was significantly lower for all types of 
HA NPs ranging from 33 to 42 MPa. 
Wagner et al. 
(2013)260  
Zirconia NPs (20 – 50 nm) were 
prepared by laser vaporisation. 
As nanofiller to improve 
the properties of 
resin/adhesive. 
Zirconia NPs were incorporated into the 
primer or adhesive of a commercial 
adhesive system at different 
concentrations (5, 10, 15, 20 wt. %). 
Mixtures were sonicated for 1h to increase 
dispersion prior to application. 
Incorporation of zirconia NPs at 20 wt. % in the primer increased the 
microtensile bond strength (µTBS) to 41 ± 13 MPa. When added at 
the same concentration to the adhesive µTBS was 32 ± 15 MPa. 
µTBS for control was 25 ± 11 MPa. 
Lohbauer et 
al. (2010)168  
CaF2 NPs (56 nm) were 
synthesised by spray-drying. 
Resin composite with 
improved mechanical 
properties and F release. 
CaF2 NPs were incorporated in a glass-
reinforced composite at 10, 20 and 30 
wt. %. Specimens were immersed in a 
NaCl solution and monitored up to 84 
days. 
The flexular strength of nanocomposites containing 10, 20 and 30 % 
CaF2 was 170 ± 20, 125 ± 15 and 100 ± 15 MPa respectively before 
immersion. After 84 days of immersion (pH 4) the corresponding 
values were 130 ± 15, 117 ± 10 and 70 ± 10 MPa. At 84 days, the F 
release was 47, 252 and 327 µg cm-2 respectively.    
Xu et al. 
(2010)170 
HA nanorods were synthesised by 
hydrothermal method. Particle size 
was not given. 
As nanofillers to 
improve the properties of 
dental adhesives. 
HA nanorods were added to an 
experimental ethanol based adhesive at 
0.2–5 wt. % and sonicated for 1 min.  
Diametral tensile strength was higher when 0.2 and 0.5 wt. % HA 
had been incorporated (35 ± 5 and 33 ± 2 MPa compared to 25 ± 5 
MPa for control). The highest flexular strength was observed at the 
same filler contents and was 50 ± 5 and 52 ± 5 MPa respectively (41 
± 4 MPa for control). Specimens with 0.2% HA had the highest 
microshear bond strength (22 ± 3 MPa compared to 11 ± 3 MPa for 
control). Flexular strength remained unchanged.    
Sadat-Shojai 
et al. 
(2010)171 
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Silica NPs (20-50 nm, mean 
diameter 26 nm) and 10-40 µm 
silica microparticles (mean 
diameter 18 µm). Silica NPs were 
treated with γ-MPS and left to dry 
for 20 days. 
As nanofillers to 
improve mechanical 
properties of dental resin 
composites. 
25 x 2 x 2 mm3 specimens were prepared. 
Specimens contained 20, 30, 40 and 50 
wt. % silica NPs or 60 wt. % micro-silica 
(control). 
Composites containing 40 wt. % silica NPs demonstrated the highest 
fracture toughness and flexular strength (1.4 ± 0.1 MPa.m1/2 and 
149.7 ± 8.1 MPa respectively). 50% filler content had the highest 
Vickers hardness (70.1 ± 3.7 VHN). Composites containing 60% 
micro-silica had similar properties with those containing 20% silica 
NPs. 
Hosseinalipou
r et al. 
(2010)172 
1 nm thick and up to 1 µm long and 
wide sodium montmorillonite (Na-
MMT) plate-like particles. 
As nanofillers to 
increase the bond 
strength of dentin 
bonding systems. 
Na-MMT particles were modified by 
methyl methacrylate by graft 
polymerisation. The modified NPs were 
incorporated into an adhesive at 0.2, 0.5, 
1, 2, and 5 wt. %. Fillers were dispersed 
by sonication.  The adhesive was applied 
to 3 mm thick human dentine discs etched 
with 35% phosphoric acid for 15 s. 
The adhesive containing 0.5 wt. % PMMA-modified Na-MMT NPs 
had the highest micro-shear bond strength (30 ± 7 MPa). The 
corresponding values for adhesives with filler content 0, 2, 1, 2, and 
5 wt. % were 26 ± 5, 24 ± 10, 24 ± 5 and 19 ± 6 MPa. The value for 
the control was 20 ± 6 MPa.   
Atai et al. 
(2009)169 
ZrO2 – SiO2 NPs were synthesised 
according to a sol-gel technique. 
Primer NPs were 50 nm and 
agglomerates up to 10 µm. 
As nanofillers to 
improve the properties of 
resin-based restorative 
materials. 
The restorative material contained 
nanofiller (23% ZrO2 /72% SiO2) at 74%. 
25 x 2 x 2 mm specimens were prepared. 
Specimens containing glass microparticles 
at the same concentration were also made 
and used for comparison. Flexular strength 
was measured after specimens were stored 
in water at 37 oC for 24 h and also after 
being stored at 37 oC for 4 weeks and then 
thermocycled 5000 times between water 
baths at 5oC and 55oC.  
Flexular strength of the specimens containing NPs was 68 ± 11 MPa 
compared to 93 ± 8 MPa for specimens with glass microparticles. 
After thermocycling, flexular strength was 42 ± 6 and 66 ± 8 MPa 
respectively. Both materials showed the same solubility (1.48 ± 0.04 
µg mm-3) and similar shrinkage (3.5 ± 0.3 and 3.0 ± 0.5 vol. % 
respectively). Water sorption (82 ± 2.6 µg mm-3) and x-ray opacity 
(27 ± 2.9 mm) of the nano-filled material was significantly higher 
compared to its micro counterpart (30 ± 6.3 µg mm-3 and 7 ± 1.1 
mm). 
Ruttermann et 
al. (2008)174 
Spherical monodisperse SiO2-based 
Ta2O5 NPs were synthesised by 
flame-spray pyrolysis (primary 
particle size was 10 nm).  
Radiopaque dental 
adhesive. 
The particle surface was functionalised 
with γ-
methacryloxypropyltrimethoxysilane in 
cyclohexane at 70oC for 24 h. The 
particles were manually mixed with the 
dental adhesive matrix and then dispersed 
by ultrasonication. The filler content was 1 
and 20 wt. %. The Ta2O5 weight fraction in 
the final powder product ranged between 
35 and 83 wt. %. Dental adhesive was 
applied to enamel and dentine of bovine 
incisors previously etched with 37% 
phosphoric acid gel. 
The method of dispersion (centrifugal mixing, sonication or both) 
was found to affect the sedimentation of the particles. Centrifugal 
mixing along with and ultrasonication gave the best results with 86% 
of the particles to be < 30 nm. Samples with 35 wt. % Ta2O5 had 
lower radiopacity than dentine (72% Al), while samples with 83 
wt. % Ta2O5 had higher radiopacity than dentine and enamel (170% 
Al). Unfilled adhesive demonstrated the strongest adhesion on 
dentine (16.1 ± 4.0 MPa) while adhesive with 20 wt. % 
functionalised filler content was most effective on enamel (26.8 ± 5.1 
MPa). 
Schulz et al. 
(2008)178  
Single-walled carbon nanotubes 
(SWCNTs) with a diameter of < 10 
nm and mean length of 15 µm. 
Resin-based composite 
with improved 
mechanical properties. 
SWCNTs were oxidised with H2SO4 and 
HNO3 for 8 h under ultrasonication and 
rinsed with ethanol. SWCNTs were nano-
The flexular strength of SWCNTs specimens was 141.1 ± 8.4 MPa 
compared to 115.0 ± 3.2 MPa for the unfilled controls.  
Zhang et al. 
(2008)175  
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coated with SiO2 by a hydrolysation 
process. 25 x 2 x 2 mm composite 
specimens were prepared containing 0.1 
wt. %  SiO2 – modified SWCNTs.  
Silica NPs. The particles used were 
7 and 40 nm in diameter and had a 
surface area of 50 and 380 m2 g-1 
respectively. NPs were treated with 
γ-MPS. 
Nanocomposites with 
improved aesthetic 
properties.  
1 mm thick composites were prepared. 
Resin matrix was loaded with 70 wt. % 
micro-fillers (Ba-glass, 1µm) and 6 wt. % 
of different combinations of 7 and 40 nm 
silica NPs. 
The contrast ratio of the specimens was found to decrease with 
increasing content in 7 nm silica NPs. Specimens containing 6 wt. % 
7 nm silica NPs exhibited the lowest contrast ratio (0.51 ± 0.03 at 
400 nm). Translucency was reduced with increasing concentration in 
40 nm silica NPs. The lowest translucency was measured for 
specimens containing 5 wt. % 40 nm NPs and 1 wt. % 7 nm NPs 
(0.78 ± 0.02).    
Kim et al. 
(2007)177  
BaSO4 NPs. Particle size was <10 
nm. 
To control the reaction 
time and mechanical 
properties of glass 
ionomers cements.  
A glass ionomer powder was manually 
mixed with 1,2,5,10,15 and 25 wt. % 
BaSO4 NPs. Six mm in height and 4 mm in 
diameter cylindrical specimens were 
prepared in moulds. 
Increasing concentration in BaSO4 NPs initially resulted in reduced 
working times and initial setting times but for higher concentration 
the effect was reversed. The shortest working time was for specimens 
with 5 wt. % BaSO4 NPs (132.4 ± 9.5 s) and the shortest initial 
setting time for 15 wt. % particle content (338 ± 10.4 s). The 
corresponding values for the controls were 155.4 ± 15.1 and 442 ± 
32.7 s. Incorporation of NPs in the glass cement decreased the 
compressive strength even at low concentrations. Compressive 
strength for samples containing 1% BaSO4 was 142 MPa compared 
to 160 MPa of the control. Samples with nanoparticle 
concentrations > 10% had reduced surface hardness too. 
Prentice et al. 
(2006)173  
Ytterbium fluoride (YbF3) NPs, 25 
nm. 
To control the reaction 
time and mechanical 
properties of glass 
ionomers cements. 
YbF3 NPs were incorporated in a glass 
ionomer cement at 1,2,5,10,15 and 25 
wt. %. Compressive strength and surface 
hardness tests were performed using 6 x 4 
mm cylindrical specimens.   
Glass cement specimens with an increasing content in YbF3 NPs 
demonstrated shorter working and initial setting times. The 
corresponding values for specimens containing 25 wt. % YbF3 NPs 
were 44.0 ± 2.9 s and 145.0 ± 6.1 s compared to 155.4 ± 15.1 and 
442 ± 32.7 s of the controls. The compressive strength of the control 
was 160 MPa. Addition of NPs at 5 and 25 wt. % reduced the 
strength values at 145 and 105 MPa respectively. Incorporation of 
NPs up to 5 wt. % increased the surface hardness of the specimens to 
43 VHN from 40 VHN but higher concentrations reduced the surface 
hardness (29 VHN for 25 wt. % NP content).  
Prentice et al. 
(2006)173  
Studies are presented in chronological order for convenience. 
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Table 3. Use of engineered nanomaterials in dental implant applications. 
Nanomaterial 
characteristics Aim of application Treatment Key results Author 
Copper (Cu) decorated multi-
walled carbon nanotubes 
(MWCNTs) were produced 
following the wet chemical 
method and using copper acetate 
as a precursor. The inside and 
outside diameters of the 
MWCNTs were 10-20 nm and 
40-60 nm respectively. The 
length of MWCNTs was 2-10 
µm. The size of Cu, Cu2O and 
CuO crystallites was 4.6, 10 and 
13 nm respectively.    
As a biocompatible 
nanocoating on Ti-6Al-
4V dental implants to 
improve the 
microstructural and 
nanomechanical 
properties of fluorapatite 
(FA)-based composite 
coatings.  
 
FA-TiO2-MWCNT-Cu nanotubes were synthesised 
following the sol-gel technique and applied to Ti-6Al-
4V specimens following a spin coating process. All Ti 
alloy specimens (10 mm x 10 mm x 1 mm) had been 
previously polished to remove original oxides and 
surface defects.    
The indentation depth for the different nanocoatings tested was FA > FA-
TiO2-MWCNT-Cu > FA-TiO2. Addition of 10 wt. % TiO2 and 1wt. % 
MWCNT-Cu was found to increase the elastic modulus of FA up to 60%. 
The elastic modulus of the FA, FA-TiO2 and FA-TiO2-MWCNT-Cu 
coatings was 11.8, 14.5 and 19.3 GPa respectively. The FA-TiO2 composite 
coating demonstrated the highest Vickers Hardness (0.72) followed by the 
FA-TiO2-MWCNT-Cu (0.58) and FA (0.37) coatings.       
Sasani et al. 
(2014)261 
HA NPs (70-80 nm) were 
produced according to an 
electrochemical deposition 
method, where Ca(NO3)2  and 
NH4H2PO4 were dissolved in 
distilled water to a Ca/P ratio of 
1.67. 
As a coating on titanium 
implants to improve 
osteoblast cell 
proliferation and 
differentiation.  
Titanium plates of 10 x 10 x 1 mm were polished, 
sandblasted and washed in 75% acetone in an ultrasonic 
bath. Before applying the nano-HA coatings, specimens 
were treated with a solution containing HF and HNO3 
and a second solution containing HCl and H2SO4. 
Murine preosteoblast cells (MC3T3-E1) were seeded at 
a density of 1x105 on each plate and cultured up to 21 
days. 
The protein content of cells growing on nano-HA coated plates (14 µg plate-
1) was significantly higher compared to the control group (5 µg plate-1) at 
early stage (day 7). The alkaline phosphatase (ALP) activity (0.5 nmol µg-1 
h-1) and octeocalcin production (1 ng µg-1 protein) of cells in the nano-HA 
group were significantly higher compared to the uncoated control group 
(0.4 nmol µg-1 h-1 and 0.75 ng µg-1 protein respectively) after 21 days of 
culture. 
Shi et al. 
(2013)262 
Carbon nanotubes (CNTs) 
synthesised by a chemical vapour 
deposition. Size was not 
specified. 
Biodegradable bioactive 
polymer-based material 
to be used in bone 
fixatives for 
maxillofacial surgery 
applications.  
CNTs were dissolved in tetrahydrofuran solvent and 
mixed with calcium phosphate (CP) and poly(lactic 
acid) (PLA). The final composites (PLA-CPNT1 and 
PLA-CPNT2) contained 0.1 and 0.25 wt. % CNTs. 
Disc-shaped specimens (1 x 10mm) were prepared in 
molds at 180oC. 4x104 pre-osteoblast cells were seeded 
on each sample and cultured for 14 days. Cell viability 
was measured by the MTS method and the cell 
differentiation into osteoblasts by the ALP activity.     
The highest tensile strength was measured for PLA samples consisting of 
50% CP and 0.25% CNTs (15.9 ± 0.9 MPa) when compared to PLA (6.0 ± 
0.9 MPa) controls. During the 14 days culture period there was an increase 
in cell growth (apart from a drop observed after 7 days for PLA-CPNT2 
samples). After 14 days, the cell growth on PLA, PLA-CPNT1 and PLA-
CPNT2 samples was 1.75 ± 0.25, 2.10 ± 0.20 and 2.15 ± 0.10 respectively. 
The corresponding values for the ALP activity were 0.16 ± 0.01, 0.21 ± 
0.03 and 0.17 ± 0.03.  
Lee et al. 
(2011)263  
HA nanocrystals (5 nm). As a dental implant 
coating. 
Screw-shaped Ti dental implants were either single or 
double coated with nano-HA. Specimens had been 
sandblasted and acid etched prior to coating. Implants 
were surgically placed in the tibia of New Zealand 
rabbits and removed after 2, 4 and 9 weeks of healing. 
The thickness of the single coating was 20 nm, and of the double 40 nm. 
Interferometry results showed that the double coated implant had the 
smoothest surface (0.77 µm) and the uncoated control the roughest (1.08 
µm). After 9 weeks of healing, the removal torque values for the control, 
single coated and double coated samples were 42 ± 10, 52 ± 10 and 48 ± 14 
Ncm respectively. The corresponding values for the formation of new bone 
were 58 ± 6, 60 ± 9 and 59 ± 13 %.   
Svanborg et 
al. (2011)191 
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CaP NPs (20-100 nm). As a coating on 
maxillofacial implants to 
improve the peri-implant 
endosseous healing 
properties. 
Implants with a CaP modified surface NPs were 
surgically placed to 15 patients and removed 3 months 
later.   
The bone area and the bone-to-implant contact (BIC) of the CaP modified 
implants were 9.1 and 13.3 % respectively while the corresponding values 
for the control implants were 8.7 and 10.8 %.  
Telleman et 
al. (2010)195 
CaP NPs. Particle size was not 
specified. 
To modify the bone 
implant surfaces. 
Ti implants (5 mm in diameter and 11.5 mm long) were 
either, alumina-blasted and dual acid-etched (controls), 
or were impregnated with low levels of Ca (0.5%) and 
P (4%). Specimens were submerged into a suspension 
of either sarcoma osteogenic cells or mesenchymal stem 
cells and incubated at 37 oC for up to 9 days. The cell 
adhesion on the implants was evaluated and also the 
cell behaviour by ALP and MTT assays.  
The average profile roughness of the control implants was 1.11 ± 0.30 µm 
and 0.84 ± 0.17 µm for those impregnated with CaP. Both cell types 
demonstrated an increasing proliferative activity over the 9 days of contact 
with the specimens. After 9 days of incubation, the MTT results for 
osteoblasts in contact with the controls were 0.32 ± 0.01 AU and 0.36 ± 
0.01 AU for cells in contact with the CaP modified specimens. The 
respective values for mesenchymal cells were 0.15 ± 0.01 and 0.13 ± 0.01 
AU. There was a reduction in the ALP activity of osteoblasts and 
mesenchymal cells in contact with both control and modified samples after 
6 days. 
Bucci-
Sabattini et 
al. (2010)196 
HA particles (1-150 nm), 
suspended in a toluene-based 
solution were used to coat Ti 
(cpTi) and titanium alloy (Ti-
6Al-4V) implants by discrete 
crystalline deposition.   
To modify the surface of 
titanium implants and 
promote 
osseointegration. 
Nano-HA modified cylindrical (2 x 1 mm) implants 
were placed in the femur of 8-week-old rats. Implants 
were harvested after 4 days, 1 week and 2 weeks for 
examination.  
Up to 1 week, healing results for modified and unmodified implants were 
similar. However, after 2 weeks the push-in value for the nano-HA coated 
cpTi implants was significantly higher (32 N) compared to untreated 
implants (20 N). For the Ti-6Al-4V implants, the push-in values were 40 N 
and 26 N respectively. The mean BIC for the coated and uncoated 
specimens was 61 ± 7 and 56 ± 11% respectively.  
Lin et al. 
(2009)188  
Rod-like nano-HA crystals. The 
cross-sectional diameter of the 
HA nano-rods was 70-80 nm.  
As a coating on porous 
titanium implants to 
promote 
osseointegration. 
Screw-shaped titanium implants (8 mm long, 3 mm in 
diameter) were coated with nano-HA by an 
electrochemical deposition technique (3.0 V, 2 h at 85 
oC). Implants were surgically placed in the proximal 
tibias of rabbits and harvested at 6 and 12 weeks 
following the operation. 
At 6 and 12 weeks, the mean BIC for the coated implants was 30 ± 5% and 
35 ± 10% respectively (20 ± 2% and 31 ± 5% for the controls). At 12 
weeks, the bone percentage within the threads inside the cortical bone was 
85 ± 10% for the implants coated with nano-HA and 82 ± 5% for the 
uncoated specimens. 
Yang et al. 
(2009)189  
Rod-shaped HA NPs (particle 
size was not specified) coated 
pure Ti screw-shaped implants 
following an electrochemical 
deposition technique. The 
thickness of the HA coating was 
1-2 µm.  
As a coating for metallic 
implants to enhance 
bone bonding, 
osseointegration and 
accelerate healing.  
Titanium implants (10 mm long, 3 mm in diameter) 
were sandblasted, dual acid-etched and heat treated with 
hydrogen peroxide before electrochemically coated 
with nano-HA. Then implants were inserted into rabbit 
trabecular bone for 2-12 weeks. 
Mean removal torque values for control samples harvested at 2, 4, 6, 8 or 12 
weeks were 21 ± 4, 24 ± 6, 50 ± 10, 42 ± 6 and 50 ± 14 Ncm respectively. 
The corresponding values for coated specimens were 40 ± 15, 40 ± 15, 50 ± 
16, 40 ± 13 and 51 ± 8 Ncm showing that surface modification with nano-
HA accelerates bone bonding and healing. After 4 weeks, results were 
similar.  
He et al. 
(2009)190  
Diamond NPs (1-50 nm). As a coating for 
orthopaedic implants to 
regulate bone growth. 
Nano-diamond (ND) coatings were produced by 
microwave plasma  enhanced chemical-vapour-
deposition and deposited on silicon wafers in the 
presence of 5-25% hydrogen gas (ND5-ND25) at 800 
oC for 2 h. Osteoblasts were seeded on specimens at a 
density of 3500 cells cm-2 and cultured for 4 h to assess 
adhesion rates and up to 5 days to evaluate cell 
ND5 and ND10 particles were 20-80 nm in diameter, while the size of 
ND15, ND20 and ND25 was considerable larger (0.2 - 2 µm). Osteoblast 
adhesion for control silicon specimens, ND coated samples, ND5 and ND10 
was 480 ± 100, 180 ± 70, 300 ± 50 and 320 ± 70 cells cm-2 respectively. For 
higher hydrogen concentrations (>15%) cell adhesion was less than 200 
cells cm-2. After 5 days of culture, there were 3800 ± 600 cells cm-2 on ND5 
specimens and 2000 ± 400 cells cm-2 on ND20. Osteoblast proliferation on 
Yang et al. 
(2009)199 
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proliferation. controls was 1000 ±400 cells cm-2.   
CaP NPs (20-100 nm). As a coating on Ti alloy 
implants to enhance 
bone formation and 
healing. 
Titanium alloy implants (2 mm in diameter and 9.5 mm 
in length) that had been previously acid etched were 
bonded with CaP nanocrystals. Implants were placed in 
the posterior maxillae of patients and retrieved after 4 
or 8 weeks.  
The histomorphometric results showed that the BIC for the CaP coated 
samples was 44.5 ± 7.4% after 4 weeks of healing and 45.3 ± 22.4% after 8 
weeks. The respective values for the non-coating implants were 15.5 ± 
4.6% and 18.3 ± 12.9%. After 4 weeks, the bone volume for the coated and 
uncoated specimens was similar, but after 8 weeks it was 44.5 ± 7.4% for 
the CaP treated samples and 18.8 ± 10.3% for the controls.  
Goene et al. 
(2007)194 
Yttrium-stabilised zirconia 
(YSZ) NPs. Single particles size 
was 50 nm. Particles formed 0.6 
µm clusters. 
Bioactive durable 
coating for biomedical 
implants. 
A composite bilayer coating of YSZ and 45S5 NPs was 
deposited on chemically etched Ti6Al4V discs with a 
surface area of 1.5 cm2. The coating was synthesised by 
an electrophoretic deposition method followed by 
sintering of the coated samples at 900 oC for 2 h.   
The produced bilayer consisted of a 5 µm thick YSZ layer and a 15 µm 
layer of 45S5-YSZ. The universal hardness value was 0.35 ± 0.09 GPa and 
the elastic modulus 16.13 ± 3.0 GPa. 
Radice et al. 
(2007)200  
Studies are presented in chronological order for convenience. 
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Table 4. Use of engineered nanomaterials in dental personal care products and proposed dentifrice applications. 
Nanomaterial 
characteristics Aim of application Treatment Key point results Author 
Polyethylene-glycol coated 
maghemite NPs (PEG-MNPs) 
were synthesised according to the 
“graft-to” method.  Particle size 
was < 25 nm. 
To treat dentine 
hypersensitivity. 
Tooth specimens were demineralised in a citric acid 
and EDTA solution for 10 min and then sonicated for 
30 min to remove the smear layer and open the 
dentinal tubules. Each specimen was immersed in 5 
mL of water containing 100 mg PEG-MNPs for 30, 
60, 90 or 120 min. An external magnetic field was 
applied in order to direct the NPs to move inside the 
tubules. 
SEM and energy dispersive X-ray spectroscopy (EDS) examination 
showed that the majority of the dentinal tubules were occluded with NPs 
following treatment with the water solution containing PEG-MNPs. The 
exposure time was found to be important and the best results were 
achieved for specimens treated for 120 min.     
Dabbagh et al. 
(2014)264 
Spherical silica NPs (12 nm) and 
HA NPs (3-5 nm). HA NPs were 
synthesised according to the sol-
gel technique. 
To encourage 
remineralisation of fully 
demineralised dentine. 
Fully demineralised dentine blocks (5 mm × 1 mm × 
1 mm) were infiltrated with colloidal solutions 
containing silica and HA NPs for 24 h and then 
immersed in an artificial saliva for up to 12 weeks. 
Infiltration of demineralised dentine with HA NPs for 24 h restored up to 
55% of the P and Ca levels. Exposure of specimens infiltrated with silica 
NPs to artificial saliva resulted in a 20% restoration of the P levels and a 
16% recovery of the mineral volume. The mineral separation after 4 
weeks of remineralisation was 18.7-20.6 µm for the silica NPs group 
compared to 15 µm for the sound control and 63.3-75.4 µm for the 
demineralised control. 
Besinis et al. 
(2014)104 
Mesoporous CaO silica (MCS) 
NPs (40 nm) were manufactured 
via a hydrothermal process.  
As a paste to treat 
dentine hypersensitivity. 
The MCS nano-paste was applied on 2 mm thick 
human dentine discs for 10 min before rinsing. Discs 
were pre-treated with 17% EDTA for 5 min.  
MCS NPs caused a nearly 100% occlusion of the dentinal tubules. The 
depth of penetration was 100 µm. MCS reduced dentine permeability. 
The fluid conductance was 13% (40% for the control desensitiser). 
Chiang et al. 
(2010)219 
Spherical silica NPs (40 nm) As a dentifrice for 
dentine hypersensitivity. 
1 mm thick dentine sections were polished, sonicated 
and etched with 37 vol. % phosphoric acid to remove 
the smear layer. Specimens were then infiltrated with 
40 wt. % silica NPs in water. Silica solutions were 
ultrasonicated for 5 min and then applied drop wise to 
dentine. 
SEM examination showed that at least 50% of the dentinal tubules were 
significantly occluded. 
Earl et al. 
(2009)99 
Calcium carbonate NPs. Particle 
size was several tens to hundreds 
of nm). 
As a dentifrice for the 
remineralisation of 
enamel lesions. 
Sections obtained from human sound molars were 
treated with a demineralising solution to create 
subsurface lesions. Sections were then treated with a 
dentifrice containing 1% calcium carbonate (CC) 
twice a day for 4 weeks. During the rest of the day 
they were stored in artificial saliva at 37 oC.  
Mineral loss for the baseline specimens (no remineralisation) was 8.0 ± 
2.2 % x µm, for the specimens treated with a dentifrice containing 1% CC 
was 4.1 ± 1.2 % x µm and for specimens treated with a non-CC dentifrice 
was 6.5 ± 2.0 % x µm. Lesion depth was 184 ± 41, 148 ± 39 and 156 ± 40 
µm respectively. Maximum mineral density was 60.2 ± 14.9, 79.6 ± 8.1 
and 66.3 ± 12.3 % respectively.   
Nakashima et al. 
(2009)215 
Calcium phosphate nanocrystals 
(<300 nm).  
To promote dentine 
remineralisation. 
Dentine specimens were etched with phosphoric acid 
for 15 s and then immersed in a solution containing 
500 mg ml-1 polyacrylic acid, 200 mg ml-1 PVPA and 
5 wt. % Portland cement. Specimens were stored at 
37 oC and remineralisation was allowed for up to 8 
weeks.  
The concentration of polyacrylic acid was found to regulate the formation 
of calcium phosphate nanocrystallites. Without polyacrylic acid the size 
of the crystals was 300 nm, while size was reduced at 75-100 nm in the 
presence of polyacrylic acid at 100 mg ml-1. For concentrations > 500 mg 
ml-1 polyacrylic acid behaved as an inhibitor and 50 nm calcium 
phosphate nanoprecursors were formed instead. Remineralisation of the 
Tay and Pashley 
(2008)100 
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collagen matrix was observed after 6 weeks. 
Carbonate hydroxyapatite (CHA) 
crystals (100 nm). 
As a paste to cover 
defects on enamel 
surface and enhance 
remineralisation. 
Enamel slabs (3 x 3 mm) were brushed three times a 
day for 15 days with a CHA toothpaste using an 
electric toothbrush. Brushing sessions were for 30 s. 
Enamel specimens were washed with tap water after 
each session.   
X-ray diffraction examination of the enamel surfaces treated with CHA 
toothpaste confirmed that CHA remained present even after brushing. 
SEM shows a thick homogenous apatitic layer of CHA on enamel 
surfaces that fills any pits or scratches. 
Roveri et al. 
(2008)217 
Spherical HA NPs (< 100 nm) 
were synthesised by sintering at 
700oC. Also needle-like HA NPs 
(60 nm in length) were 
synthesised by precipitation. 
As a paste to promote 
remineralisation. 
Solutions of spherical and needle-like HA NPs as 
well as a mixture of both types (particle size < 2µm) 
were added to a toothpaste without sodium fluoride. 
Specimens (human premolars with artificial caries) 
were treated for 5 and 10 days.  
The hardness of demineralised enamel was 104 HV and that of sound 
enamel 287 HV. After 5 days of treatment with spherical H NPs, needle-
like HA and mixed HA the hardness of the specimens was 190, 200 and 
150 HV respectively. After 10 days of remineralisation the corresponding 
values were 255, 260 and 175 HV. 
Lv et al. 
(2007)210 
45S5-type bioactive glass NPs 
were synthesised by flame spray 
synthesis. Particle size was in the 
range 20-50 nm. 
To increase the mineral 
content of dentine.  
Dentine specimens previously demineralised with 
17% EDTA for 2 h, were immersed in suspensions of 
glass NPs or micro-glass at 37 oC for 1, 10 and 30 
days. 
In the slurry with nano-glass there was a rapid increase in the release of 
Ca2+ and dissolved silica. After 24 h the concentration values were 67.8 ± 
3.7 ppm and 22.3 ± 0.3 mg l-1 respectively. Saturation levels had been 
reached within 6 h. Final ion concentrations for the slurry with micro-
glass were 16.6 ± 2.6 and 2.6 ± 0.7 mg l-1. After 30 days of 
remineralisation, the mass loss (after calcinations) for the samples 
infiltrated with nano-glass was 25 ± 3% (32 ± 3% for microglass) 
suggesting higher mineral content. The Young’s modulus of the 
infiltrated samples was not different than demineralised dentine (6.6 ± 1.2 
GPa).    
Vollenweider et 
al. (2007)213 
Rod-shaped HA NPs synthesised 
by a hydrothermal technique. 
NPs were 100 nm long and 30-60 
nm in diameter. 
As a dentifrice for the 
treatment of dentine 
sensitivity. 
Dentine sections were obtained from human molars 
and 1 mm thick dentin discs were prepared. 
Specimens were etched with 37 vol. % phosphoric 
acid solution for 60 s and then infiltrated with 0.5 
wt. % nano-HA suspensions in methanol. Prior to 
application suspensions were ultrasonicated for 5 
mins.   
50% of the dentinal tubules were fully occluded and another 40% had at 
least half of their cross-sectional area blocked by HA NPs. 
Earl et al. 
(2006)98 
Nano-HA. Particle size was not 
specified. 
As a paste to 
remineralise enamel. 
Subsurface enamel lesions were induced to 
permanent teeth. Specimens were then treated with 
two toothpastes slurries. Both were prepared by 
mixing 100 g of toothpaste in 100 ml distilled water. 
One slurry contained nano-HA with sodium 
monofluorophosphate (0.65%) and the other nano-
HA but excluded fluoride. Enamel specimens 
remained static in stirred solutions and 
remineralisation was for 24 or 48 h. 
The Vickers Hardness Number (VHN) for sound enamel was 326 ± 25.5 
and for demineralised specimens 293.2 ± 18.1. After 24 h and 48 h of 
remineralisation with the slurry containing nano-HA and fluoride the 
VHN were 298.8 ± 19.7 and 316.7 ± 14.1 respectively. For specimens 
treated with nano-HA but no fluoride the corresponding values were 
312.3 ± 14.2 and 315.4 ± 14.1 
Jeong et al. 
(2006)208 
Studies are presented in chronological order for convenience. 
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Table 5.  Literature data on the toxicity of engineered nanomaterials from in vivo oral exposure studies. 
Engineered 
Nanomaterial Dose  Exposure Method Species Toxic Effects Author 
Au NPs (20 nm) and 
Ag NPs (20 nm). 
1 M kg-1 or 2 M kg-1 
of each ENM daily. 
Exposed once daily for 
14 days by oral gavage. 
Male Swiss albino mice 
(25-30 g). 
Exposure to the NPs caused body weight loss, which was higher for Ag NPs 
compared to Au NPs and more evident at the highest concentration (2M) tested. The 
blood and tissue (brain, liver, kidney, and spleen) oxidative stress levels were 
elevated for all groups compared to control showing that both ENMs produced 
toxicity. Ag NPs were found to be more toxic for all organs except the spleen where 
Au NPs caused more toxicity. The toxic effect was dose dependant for both NPs.    
Shrivastava et al. 
(2014)265 
125I labelled graphene 
oxide and 
polyethylene glycol 
(PEG) functionalized 
grapheme oxide 
derivatives. 
100 ml of 20 µCi per 
mouse of 125I, a 
single dose of 4 mg 
kg-1 of each ENM. 
Sampling at 1, 7 and 
30 days post dosing. 
Orally injected with the 
dispersion, single dose. 
Female balb/c mice. 125I labeled PEGylated grapheme oxide derivatives show no obvious uptake to the 
internal tissues oral administration. Radioactivity in the stomach and intestine 
increased by day 4 post-exposure. No changes in haematology were observed. 
Yang et al. 
(2013)266 
< 20 nm non-coated 
(NM300K), 
or <15 nm PVP-coated 
Ag NPs, AgNO3, or 
carrier solution only 
(NM300KDis). 
Ag NPs : 90 mg Ag 
kg-1 body weight 
(bw). AgNO3, 9 mg 
Ag kg-1 bw.  
Exposed daily for 28 
days by oral gavage. 
Dosing volume was 3.3 
ml kg-1 bw. 
Male Sprague-Dawley 
rats, 6 weeks old. 
Silver was present in all examined organs with the highest levels in the liver and 
spleen for all silver treatments. Silver concentrations in the organs were highly 
correlated to the amount of total Ag in the Ag-NP suspension, indicating that 
dissolved silver, and to a much lesser extent, Ag NPs, passed the intestines in the Ag-
NP-exposed rats. In all groups silver was cleared from most organs after 8 weeks 
post-dosing, but not from the brain and testis. 
van der Zande et al. 
(2012)19 
Poly(amido amine) 
dendrimers and silica 
NPs of different size 
(50-200 nm), surface 
charge, and surface 
functionality. 
0.2 ml of single 
escalating doses per 
mouse were 
administered starting 
from 3 or 10 mg kg-1 
at half-log dose 
increments (up to 
1000 mg kg-1)  
All test compounds 
were dispersed in sterile 
physiological saline 
(filtered through 0.2 mm 
filters) and injected 
intravenously by tail 
vein injections. Animals 
were monitored for 10 
days. 
CD-1 (caesarean derived-
1) mice. 
A distinct trend in nanotoxicity based on surface charge and functional group was 
observed with dendrimers regardless of their size. Amine-terminated dendrimers 
were fatal at doses >10 mg kg-1 causing haematological complications, whereas 
carboxyl- and hydroxyl-terminated dendrimers of similar sizes were tolerated at 50-
fold higher doses. Larger silica NPs were less tolerated than smaller silica NPs 
irrespective of their surface functionality. 
Greish et al. 
(2012)267 
Al2O3 (30 nm and 40 
nm).  
Al2O3 (bulk, size not 
specified). 
ENMs were 
suspended in 1% 
Tween-80. Doses of 
500, 1000 and 2000 
mg kg-1. 
Single oral doses 
(precise method not 
specified). Animals 
observed for 14 days. 
Adult female albino 
Wistar rats, 8–10 week 
old. 
Aluminium concentrations are not reported in the tissues. Inhibition of hepatic 
superoxide dismutase at day 3 post-exposure, mostly lost by day 14 post-exposure. 
Hepatic catalase increased with no clear difference between the materials. The 
authors report a dilated central vein and expanded portal tract, but there are no 
quantitative histological measurements to support the claim. 
Prabhakar et al. 
(2012)268 
Single-walled carbon 
nanotubes (SWCNT), 
1.1 nm mean outside 
diameter, 5-30 µm 
length, compared to 
carbon 60. 
Control, 10, or 500 
mg kg-1 SWCNT or 
C60 for 6 weeks.  
ENMs incorporated into 
animal feed. 
Rainbow trout 
(Oncorhynchus mykiss) 
Normal growth and haematology indicated no overt toxicity. A transient oxidative 
stress was observed in the brain as measured by thiobarbituric acid reactive 
substances (TBARS). Two animals from the C60 treatment showed liver pathology 
including necrosis and vacuole formation in the parenchyma. 
Fraser et al. 
(2011)234 
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TiO2 (5 nm) Control, 5, 10 or 50 
mg kg−1 every day 
for 60 days. 
Intragastric 
administration of 
repeated daily dose. 
Mice The Y-maze test showed that TiO2 NPs exposure could significantly impair the 
behaviors of spatial recognition memory. Moreover, TiO2 NPs significantly inhibited 
the activities of Na+/K+-ATPase, Ca2+-ATPase, Ca2+/Mg2+-ATPase, acetylcholine 
esterase, and nitric oxide synthase. Cholinergic neurotransmitters were also affected.  
Hu et al. (2010)42 
TiO2 (50 and 120 nm). 
Crystal structures not 
specified. 
Suspensions of TiO2 
(5 g kg-1 bw), lead 
acetate (500 mg kg-1 
bw), or combined 
dosing of the above 
(TiO2 + lead acetate) 
for 7 days. 
Oral gavage. 0.1 ml 10 
g-1 bw, daily for 7 days.  
 
Laboratory-bred Kun 
Ming mice, female and 
male, 6–8 weeks old. 
Note, food and water provided 2 h after each gavage. Elevation of total Ti metal 
concentrations in the liver, kidney and brain at 7 days post exposure. Combined 
exposure with lead acetate increased the apparent Ti accumulation. Tissue Pb 
concentrations also increased in the combined exposure. Authors interpret 
histopathology as “deranged and swollen” cells in the liver, swollen renal tubules, 
and necrotic cells in the hippocampus. However, the histology was not quantitative 
with no incidence or criteria for histological reporting described. 
Zhang et al. 
(2010)269 
 
P25 TiO2 NPs (21 
nm); 75% anatase and 
25% rutile.    
Control, 10, or 100 
mg kg-1 TiO2 NPs 
diets for 8 weeks 
followed by a 2 week 
recovery.  
ENMs incorporated into 
animal feed. 
Rainbow trout 
(Oncorhynchus mykiss) 
Ti accumulation in gill, gut, liver, spleen and brain. Adverse effects included 50% 
inhibition of the brain Na+/K+-ATPase activity, but there were no effects on growth.  
Ramsden  et al. 
(2009)233 
“Aeroxide” P25 TiO2 
(21 nm); 75% anatase 
and 25% rutile.    
0, 60, 120, 300 and 
600 mg l-1 
concentrations for 5 
days. 
Drinking water, 5 ml 
water intake for average 
30 g mouse. 
C57Bl/6Jpun/pun adult 
male mice.  
DNA strand breaks indicated by increased tails on alkaline comet assay in peripheral 
blood cells. Increased micronuclei incidence to about 9/1000 red blood cells. mRNA 
for pro-inflammatory cytokines up regulated. 
Trouiller et al. 
(2009)270 
TiO2 NPs (25 and 80 
nm), compared to 155 
nm material.  
 
5 g kg-1 for 2 weeks. Single oral gavage. Adult mice The accumulation of Ti metal from nanoscale TiO2 (25 and 80 nm) occurred in the 
spleen, kidney, lung, brain and liver; depending on particle size. Organ pathologies in 
the liver interpreted as hydropic degeneration around the central vein and the spotty 
necrosis of hepatocytes. Blood urea nitrogen elevated in the 25 nm TiO2 treatment, 
interpreted as renal dysfunction.   
Wang et al. 
(2007)231 
Cu NPs (23.5 nm), Cu 
microparticles (17 
µm), or CuCl2 metal 
salt. 
Control, 500-5000 
(micron powder), 
108-1080 (nano), 24-
237 (metal salt), in 
mg kg-1. 
Single oral gavage. Imprinting control region 
(ICR) mouse model, 8 
weeks old. 
The LD50 values for the nano-, micro-copper particles, and CuCl2 were 413, >5000 
and 110 mg kg-1 body weight, respectively. Nanoscale material caused atrophy of the 
spleen with fibrosis. Mild steatosis reported in the liver, and moderate tubular 
necrosis in the kidneys of Cu NP-exposed mice. 
Chen et al. 
(2006)232  
Studies are presented in chronological order for convenience. 
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